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ABSTRACT
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Congenital heart defects (CHD) are the most prevalent birth defect in the world and occur
in approximately 6-8 of every 1,000 live births (Hoffman & Kaplan, 2002). CHD
continues to be one of the leading causes of infant morbidity and mortality today. Five to
ten percent of all cases of CHD can be attributed to a chromosomal abnormality, 3%-5%
are linked to single gene defects, and approximately 2% are a result of known
environmental factors (Clark, 2001). With only 10%-15% of the causes of CHD are
understood, the remaining 85%-90% of all CHD cases, the etiologies remain unknown.
The purpose of this study was to examine the relationships of select maternal variables to
the type of CHD (simple vs. complex), birth weight and gestational age in infants born
with CHD participating in the Wisconsin Pediatric Cardiac Registry (WPCR). This study
was a secondary analysis of 1,687 parent/child questionnaires using the data within the
WPCR database from 2000-2010. A life course perspective was used to organize the
maternal context variables and illustrate the relationships to the birth outcomes of the
infants with CHD. The findings in this study included two maternal variables as risk
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factors for having a child with complex CHD. Personal maternal history of CHD (OR:
2.382; 95 % CI: 1.424-3.984) and history of serious health condition (OR: 1.537; CI:
1.085-2.178) increased the risk for complex CHD in these infants. The predictors of birth
weight included; maternal history of hypertension, serious health condition six months
prior/during pregnancy, CHD, obesity and income (R² = 0.049, p < 0.05). The predictors
of gestational age included; maternal history of hypertension, flu, and serious health
conditions 6 months prior/during pregnancy, and type of housing (R² = 0.045, p < 0.05).
Nurses and healthcare providers can identify risk factors prior to pregnancy and provide
education to women and their partners in anticipation for a future pregnancy to reduce
risk of complex CHD in their infant. This study reinforces the multifaceted nature of
CHD and need for further investigation of maternal and paternal exposures to help
identify other risk factors for complex CHD.

iii

© Copyright by Mary R. Butler, 2014
All Rights Reserved

iv

DEDICATION
With all my love, to my family:
My husband James
My son Dominic
My mom Teresa,
My sister and her family, Sue, Tony, Abby and Gabby
And my late grandmother Leonella, a visionary and inspiration.
You have all supported me in the journey during the tough times and the joyous times. I
could not have completed this without each and every one of you. Words cannot express
the appreciation and love I have for you all. Thank you.

v

ACKNOWLEDGEMENTS
I would like to express my deepest appreciation to Dr. Kathleen Sawin, my major
professor, for guiding me in this journey. We both have learned so much in this process
about CHD. Your in-depth knowledge and expertise in research have given me the skills
and ability to push forward as a nurse leader in this field. I am forever indebted to you as
I continue in my career.
My dissertation committee has been a gift from the beginning. I would like to
thank Dr. Teresa Johnson and Dr. Michael Carvan for sharing their expertise and
knowledge to develop this dissertation and assist me in improving my ability to present
these findings. You both have been active members of my committee from the beginning,
providing guidance and constructive criticism to challenge my writing and understanding
of these concepts. Dr. Strasburger, you have been a wonderful mentor and colleague
urging me to pursue higher education. I am forever grateful for your ability to push me to
a level of expertise I would have never envisioned for myself. Thank you, Dr. Morin for
your critique and suggestions on the final dissertation. It was a privilege and honor to
work with each of you.
A special thank you goes to my co-workers who have urged me forward at times
of frustration. I appreciate the patience you all had during this process.
Finally, I would like to express my gratitude to the Herma Heart Center for
allowing me the use of the WPCR data to conduct this study in my dissertation. I could
not have completed this study without the generous assistance of the WPCR coordinators
and research team.

vi

TABLE OF CONTENTS
PAGE
TITLE PAGE ................................................................................................................. i
ABSTRACT .................................................................................................................. ii
COPYRIGHT PAGE ................................................................................................... iv
DEDICATION ...............................................................................................................v
ACKNOWLEDGEMENTS ......................................................................................... vi
LIST OF FIGURES ..................................................................................................... xi
LIST OF TABLES ...................................................................................................... xii
CHAPTER ONE: INTRODUCTION ...........................................................................1
Study Problem and Purpose ...............................................................................5
Theoretical Framework ....................................................................................10
Hypotheses .......................................................................................................12
Definitions of Terms ........................................................................................12
Methods............................................................................................................18
Study Summary................................................................................................22
Manuscripts ......................................................................................................24
CHAPTER TWO: REVIEW OF LITERATURE/MANUSCRIPT ONE: Association of
Maternal Risk Factors and Congenital Heart Defects..................................................25
Chapter Introduction ........................................................................................25
Abstract ............................................................................................................25
Introduction ......................................................................................................26
A Life Course Perspective ...............................................................................28
Aim ..................................................................................................................29
vii

Methods............................................................................................................29
Results ..............................................................................................................30
Discussion ........................................................................................................36
Validity and Relevance ....................................................................................37
Relevance to Clinical Care...............................................................................38
Conclusion .......................................................................................................40
References ........................................................................................................42
CHAPTER THREE: MANUSCRIPT TWO: Maternal Health and Infants born with
Congenital Heart Disease: A Secondary analysis of the WPCR .................................62
Chapter Introduction ........................................................................................62
Abstract ............................................................................................................62
Introduction ......................................................................................................63
The Basic Building Blocks of Life ..................................................................65
Genetics of CHD ..............................................................................................67
Single Gene Mendelian Mutations.......................................................68
Chromosomal Abnormalities ...............................................................70
Multifactorial Inheritance ....................................................................72
Research Implications ......................................................................................73
Clinical Implications ........................................................................................74
Conclusion .......................................................................................................76
References ........................................................................................................77
CHAPTER FOUR: MANUSCRIPT THREE: Maternal Health and Infants born with
Congenital Heart Disease: A Secondary analysis of the WPCR .................................85
Chapter Introduction ........................................................................................85
viii

Abstract ............................................................................................................85
Conceptual Framework ....................................................................................88
Methods............................................................................................................89
Design ..................................................................................................89
Setting and Participants............................................................90
Measures ..............................................................................................90
Statistical Analysis ...............................................................................91
Results ..............................................................................................................93
Discussion ........................................................................................................96
Statistical Considerations and Limitations...........................................99
Implications for Practice and Research..........................................................100
Summary ........................................................................................................102
References ......................................................................................................104
CHAPTER FIVE: ANALYSIS OF THE MANUSCRIPTS .....................................120
Chapter Introduction ......................................................................................120
Synthesis of the Manuscripts .........................................................................120
Limitations .....................................................................................................131
Implications....................................................................................................133
Theory ................................................................................................133
Practice ...............................................................................................135
Education ...........................................................................................137
Future Research .................................................................................138
Policy .................................................................................................139
ix

Conclusion .....................................................................................................140
REFERENCES ..........................................................................................................142
APPENDICES ...........................................................................................................157
APPENDIX A: WPCR Approval Letter ........................................................158
APPENDIX B: WPCR Maternal Questions from Questionnaire .................159
APPENDIX C: Approval to Reuse Material: Molecular Mechanisms ..........164
APPENDIX D: Approval to Reuse Material: A Genetic Blueprint ..............165
APPENDIX E: IRB Approval Letter ............................................................169
CURRICULUM VITAE ............................................................................................171

x

LIST OF FIGURES
FIGURE 1 - Chapter 1: Conceptual Framework ........................................................15
FIGURE 1 - Chapter 2: Literature Search Process .....................................................52
FIGURE 1 - Chapter 3: Cardiac Formation ................................................................81
FIGURE 2 - Chapter 3: Patterns of Inheritance ..........................................................82
FIGURE 3 - Chapter 3: Clinical Exemplars ...............................................................83
FIGURE 1 - Chapter 4: Conceptual Framework ......................................................110
FIGURE 2 - Chapter 4: Callouts ...............................................................................111

xi

LIST OF TABLES
TABLE 1 – Chapter 2: Evidence Table, Biologic Maternal Contexts .......................53
TABLE 2 – Chapter 2: Evidence Table, Physical Maternal Contexts .........................56
TABLE 3- Chapter 2: Evidence Table, Social Maternal Contexts ..............................59
TABLE 1 – Chapter 3: Genetic Causes of CHD .........................................................84
TABLE 1 – Chapter 4: Questions Used in Analysis..................................................112
TABLE 2 – Chapter 4: Infant Demographic Characteristics .....................................112
TABLE 3 – Chapter 4: Maternal Demographic Characteristics ................................113
TABLE 4 – Chapter 4: Maternal Health and Substance Use.....................................114
TABLE 5 – Chapter 4: Logistic Regression ..............................................................114
TABLE 6– Chapter 4: Hierarchical Multiple Regressions ........................................115
TABLE 7 – Chapter 4: Correlations- Biologic Maternal Contexts ...........................116
TABLE 8 – Chapter 4: Correlations- Physical Maternal Contexts............................117
TABLE 9 – Chapter 4: Correlations- Social Maternal Contexts ...............................118
TABLE 10 – Chapter 4: Correlations- Simple/Complex, CHD, BW, GA ................119

xii

1
CHAPTER ONE
The Influence of Maternal Contexts on Infant Outcomes
Congenital heart defects (CHD) are the most prevalent birth defect in the world
and occur in approximately 6-8 of every 1,000 live births (Hoffman & Kaplan, 2002).
CHD continues to be one of the leading causes of infant morbidity and mortality today.
Five percent to ten percent of all cases of CHD can be attributed to a chromosomal
abnormality. And another 3%-5% are linked to single gene defects, and approximately
2% are a result of known environmental factors (Clark, 2001). With only 10%-15% of
the causes of CHD are understood, the remaining 85%-90% of all CHD cases, the
etiologies remain unknown.
CHD is the most common birth defect in the United States in children and adults
with approximately 1,040,106 new patients are diagnosed each year (Gibson, Burns,
Walker, Cross, & Leslie, 2010). Understanding and identifying the risk factors associated
with CHD is critical in reducing the financial and social constraints placed on the
individual and society and the individual (Jacobs, Wernovsky, & Elliot, 2007) and
decreasing the prevalence of CHD. There are many types of CHD, with many being
simple such as an atrial septal defect (ASD) to the very complex, hypoplastic left heart
syndrome (HLHS). As children with complex CHD survive into adulthood as a result of
advances in treatment and diagnosis respectively the numbers of adults with complex
CHD are increasing twofold as well. It is estimated a lifetime cost for children in the
U.S. with complex CHD can be in excess of $1.2 billion (CDC, 2010). In 2004 it was
estimated that hospital care for all patients with CHD, children and adults, exceeded $2.6
billion (AHA, 2009). As the adult CHD population grows, researchers predict that
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numbers of adults with CHD will surpass the number of children with CHD in the next
decade. The cost of care for complex CHD produces significant financial strains on
families, healthcare systems and society that have been recognized as a public health
problem. These issues have led researchers to gain greater understanding of the etiology
of CHD development in the fetus thus try to decrease the prevalence.
Although treatment for CHD has evolved dramatically over the years, it’s etiology
continues to be elusive. In the past, children born with cyanotic heart disease (causing
low blood oxygen levels) were treated only with palliative measures with most children
dying early in infancy. Of those children who survived, most had significantly shorter
life spans before diagnostic and surgical technologies were available. Cardiac
angiography was the first diagnostic tool developed in the 1930’s to visualize cardiac
malformations. Shortly after catheterizations, surgical ductus ligation, surgical
correction, and palliative surgical techniques followed for treatment of cyanotic heart
defects with great success in the 1940’s (Emmanouilides, 2001). The first
cardiopulmonary bypass procedure was successfully performed in 1953. This novel
procedure was one of the first doors to be opened for surgical care and treatment of
congenital heart disease. These ground breaking diagnostic and surgical techniques
created a new group of complicated children and adults with a chronic health condition to
care for in our society (Emmanouilides, 2001).
Over the last 75 years, successful advances in the identification of the many
structural forms of CHD, methods for surgical correction, and palliative procedures have
dramatically decreased mortality from 50% to almost 15% (Emmanouilides, 2001).
Although many milestones have been accomplished in the diagnosis and treatment of
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CHD, the etiology remains elusive. Epigenetics, the study of the biological processes in
which heritable genetic changes not found in DNA sequencing influence gene function at
various stages of development is a growing area of interest in the study of CHD. The
environmental exposures incurred over generations and the genetic predispositions to
specific health conditions such as CHD are areas of great interest for research.
Identification of biologic, physical and social risk factors for giving birth to an infant
with CHD in women of childbearing are goals of many researchers and clinicians.
Through use of animal models and the recent ability to sequence the human
genome, a greater understanding of the molecular and genetic influences during fetal
development of the heart has allowed researchers and clinicians the ability to identify
critical times of vulnerability and target potential interventions. Pre- and inter-conception
timeframes are now understood as critical times to focus in the mother’s exposures and
their influence during fetal cardiac development (Sartiani et al, 2009). The epigenetic
factors influencing the activation or inactivation of cardio-specific genes during cardiac
development are being studied and are better understood. Therefore the environmental
exposures that are potentially triggering these cellular processes are of great interest for
researchers and clinicians due to the multifactorial nature of CHD.
Although the exact mechanism of CHD development during pregnancy when a
women are exposed to some medications, vitamins, alcohol or tobacco use, and some
environmental toxins is not well understood, there has been an observed risk for CHD
development in the fetus from these agents (Brent, 2004). Due to the heterogeneity of
CHDs in humans and ethical considerations in human studies, understanding the exact
mechanisms in cardiac formation and CHD development have been complicated. Several
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cardio specific genes (GATA, Nkx, Hand, EGFR, Wnt5a), transcription factors (ZIC3,
NKX2.5, TNX5, GATA4, TFAP2B, TBX1 and FOG2) (Clark, Yutzey & Benson, 2006)
and epigenetic processes (histone modifications, RNA modifications, and DNA
methylation) are known to be essential in normal cardiac development. Researchers have
identified errors occurring in several genes, transcription factors, chromosomes, and
single nucleotide polymorphisms that are responsible for specific CHDs in both animal
models and humans (Bentham & Bhattacharya, 2008; Hinton, Yutzey, & Benson, 2005;
Huang, Liu, & Lv, 2010; McFadden & Olson, 2002; Reamon-Buettner, Spanel-Borowski,
& Borlak, 2005).
Cardiac development is a complicated process of cell proliferation,
differentiation, migration and morphogenesis creating the potential for disruption of one
or many of the multiple pathways. The gene-environmental interaction theory (Nora,
1968) and its influence of CHD development is complex due to the multifactorial nature
complicating identification of specific etiological sources of CHD. Researchers and
clinicians cannot underestimate the various exposures a woman encounters throughout
her lifetime and the potential impact it may have on her developing infant. As further
genetic and environmental research is conducted, greater understanding of these complex
processes may provide nurses and clinicians recommendations for treatments promoting
preventative prenatal health care practice guidelines for the reduction of CHD and the
costs associated with its care.
Specific biologic, physical, and social variables during various times of pre-and
inter-conception and pregnancy are areas for researchers and practitioners alike to
intervene and study. The Centers for Disease Control and Prevention have published
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routine updates on the Public Health Action Plan to Prevent Heart Disease and Stroke
including investigation of the environmental causes of CHD and cardiovascular disease
(CVD) (CDC, 2011). The National Heart, Lung, and Blood Institute (NHLBI) created a
task force in 2001 specifically focusing on pediatric cardiovascular disease identifying
research priorities, and scientific opportunities to address the growing public health
problem of CHD in children and adults (NHLBI, 2002).
Etiological and epidemiological research are important when trying to identify
causal sources of CHD. This type of research has implications for prenatal, pediatric, and
adult care in counseling and identification of risk factors associated with CHD in these
groups. However, this research is also instrumental when transitioning these children
with CHD into a healthy adulthood. Health care providers (HCPs) need to provide
adequate counseling for their reproductive health as some forms of CHD are familial.
Continued epidemiologic, environmental, and genetic CHD research will assist in the
identification of the risk factors and causal factors associated with CHD to significantly
decrease or eliminate CHD in humans (Weinhold, 2004).
Study Problem and Purpose
During the review of literature several reviews of maternal risk factors for CHD
were discovered. These investigators identified specific maternal risk factors for CHD
but, none of which contained all of the maternal contexts of interest in one study (Gorini,
Chiappa, Gargani, & Picano, 2013; Luteijn, Brown, & Dolk, 2013; Patel & Burns, 2013;
Stothard, Tennant, Bell & Rankin, 2009; Jenkins at al., 2007; Thulstrup & Bonde, 2006;
Watson, Jacobson, Williams, Howard & DeSesso, 2006; Lin & Ardinger, 2005). The
genetic research was extensive; however the understanding between environmental risk
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factors and genetic risk factors remains unknown. The Baltimore Washington Infant
Study (BWIS) was the only study identified which separated the type of CHD into
categories of severity and evaluated biologic and environmental risk factors (Ferencz,
Loffredo, Correa-Villaseñor & Wilson, 1997).
Pediatric cardiologists around the state of Wisconsin became aware of the
increasing number of infants born with single ventricle physiology in the late 1990’s.
After much discussion and review, these cardiologists, and a large interdisciplinary team,
created the Wisconsin Pediatric Cardiac Registry (WPCR) in 2000. This database,
modeled after the BWIS (Ferencz et al., 1997), was created to help identify and track data
associated with CHD in infants born in Wisconsin. The goal for creation of this
comprehensive database was to gain a greater understanding of the influences of maternal
and paternal exposures before and during the pregnancy that might increase the risk of
CHD development in the infant. This database includes the temporal, epidemiological,
and demographic variables that may reflect risk factors for the birth of an infant with
CHD. The WPCR project has collected environmental exposure history, family history
and genetic data for analyzing to aid in understanding the etiology of CHD.
The WPCR was the first large heart defect database-registry to collect subjective
and genetic information from histories of mothers, fathers, and infants born in Wisconsin
with various forms of CHD (Hanson-Morris, Pelech, 2006). The WPCR was created
with three overarching goals (Harris et al., 2011):
1.

Ascertain all families with an infant/child born with a congenital heart
defect in the state of Wisconsin and provide a detailed phenotypic
description of the anomaly.
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2. Obtain both DNA samples and complete questionnaires from all
ascertained families and also a control group.
3. Initiate and promote collaborative research into genetic and environmental
etiologies of CHDs, utilizing data and specimens from the WPCR (p. 24).
Over the last 15 years several publications using the data from the WPCR have
been presented. An overview of the structure of the WPCR and goals for the collection
of the data and potential for studies using the data within the WPCR were published by
Cronk et al. (2003), Hanson-Morris and Pelech (2006), and Harris et al. (2011). In Cronk
et al’s two studies (2004, 2011) geographical distribution of several types of CHD were
explored in Wisconsin using data from the WPCR database. Presently, there are no
published studies using the maternal data from the WPCR.
The first goal of the WPCR was most pertinent to this study. It is estimated that
CHD prevalence is 0.5%-0.8%, or approximately 400-600 new cases each year occur in
Wisconsin (Hanson-Morris & Pelech, 2006). In this study the completed questionnaire
data were used to evaluate relationships between maternal demographics and exposures
prior to and during the pregnancy and the type of CHD of their infants. There have been
no published results from 2000-2010 using WPCR data examining maternal factors for
risk of type of CHD. In the literature the majority of studies have identified maternal risk
factors for CHD development for the general population. Few studies have identified risk
factors associated with the type of CHD.
The BWIS was the first large population based study to examine the risk factors
of CHD development in the general population. This study also examined the
relationships between the genetic and environmental risk factors and the various CHD
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phenotypes (Ferencz et al., 1997). The BWIS found evidence of increased risk with
certain types of CHD and hypothesized that certain risk factors may be more prevalent
during particular times of cardiac formation. The BWIS demonstrated an increased risk
for laterality/looping defects (OR 8.3, 95% CI 3.0-23.0), atrioventricular septal defects,
nonchromosomal (OR 10.6, CI 3.7-30.6), and cardiomyopathy (OR 11.5, CI 4.4-29.8)
when maternal diabetes was present (Ferencz et al., 1997). They also found increased risk
for specific types of CHD when several other maternal variable were present including
history of fever, influenza, family history of CHD, maternal age > 30years, and use of
diazepam.
The current study examined maternal risk factors related to complex CHD in
these infants as this question has not been examined to date. A power analysis based on
the work of Peduzzi et al. (1996) was performed to determine adequacy of size of the
sample. Using the formula of N=10k/p (k=number of covariates) (p=the smalls of the
proportion of negative or positive cases) N=10(15)/.3, N= 500; 500 cases were required
for this study. With 1,687 completed questionnaires available adequate power to
determine relationships among the variables was present. Hypotheses were derived from
a review of literature and review of the information collected by the WPCR. This study
may provide identifiable and modifiable risk factors for women with history of an infant
with CHD to decrease the risk for having a subsequent pregnancy affected by CHD.
Maternal health and exposures have also been associated other birth outcomes
including birth weight and gestational age. Low birth weight and early gestational age
have been associated with certain maternal risk factors such as chronic health conditions
(Palmer, Bonzini, Harris et al., 2013), history of smoking (Ashford et al., 2010; Rogers,
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2009) , and socioeconomic status (Blumenshine, Egerter, Barclay, Cubbin, & Braveman,
2010; Jansen et al., 2008; Messer et al., 2008). In this group of infants with various types
of CHD, it is hypothesized that these maternal risk factors are also associated with the
infants’ birth weight and gestational age as well as type of CHD. It is important for
women to optimize their health prior to and during pregnancy to decrease the risk for low
birth weight and premature birth. Infants with complex CHD were also believed to be at
greater risk for low birth weight and prematurity due to the complexity of CHD diagnosis
(Williams et al., 2010; Malik, Cleves, Zhao, Hobbs, & NBDS, 2007).
The same questionnaire was used consistently from 2000-2010, thus providing
large amounts of data to be explored. In 2006 a control group was initiated to provide
comparisons of children without CHD. However, there were never enough control
subjects to meet the goal of the registry. The majority of the comparison groups were
older children or teenagers found to have normal cardiac structures on echocardiography,
with approximately 270 controls available. There were approximately 50 controls who
completed a questionnaire that was an abbreviated version if over the age of two years.
These children were older therefore their parents were less likely able to complete the
questionnaire accurately, due to recall issues. Therefore in this study the control group
was not used. The genetic information collected was not used for this study.
A secondary analysis of the maternal context variables in the WPCR was
completed using this large data set collected over the last 10 years. Through
identification of the relationships between these maternal context variables and the
outcome or type of CHD nurses and researchers may be provided with new evidence of
risk factors in this population. From a critical review of literature of the contextual and
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genetic maternal risk factors for CHD development, a specific aim was developed with
two hypotheses to be tested and one exploratory research questions to be posed. The
specific aim of this study was to examine the relationships of select maternal context
variables to the type of CHD (simple or complex), birth weight and gestational age in
infants born with CHD participating in the WPCR.
Theoretical Framework
The central tenets of nursing include person, environment, health, and nursing
(Flaskerud & Halloran, 1980; Yura & Torres, 1975). Nursing has a goal to provide a
holistic model of healthcare delivery incorporating research findings to guide practice.
Both nursing and the life course theory have a goal of improving health and
understanding disease processes. Therefore a life course perspective on health was
chosen as a theoretical model to guide this study as this theory conceptualizes health as a
reflection of an underlying developmental trajectory. The goal of the life course
perspective is to understand, explain, and improve health and disease patterns across
various populations (Halfon & Hochstein, 2002). The key concepts of the life course
theory include:


Timeline – health is cumulative and longitudinal, i.e., developed over a lifetime.



Timing - health and health trajectories are particularly affected during
critical/sensitive periods.



Environment – the broader environment (biologic, physical, and social) affects
health and development.



Equity – health inequality reflects more than genetics and personal choice. (Fine
& Kotelchuck, 2010).
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The life course perspective uses a multidimensional approach incorporating
biological, psychological, behavioral, and social contexts to explain health and disease
processes allowing for intervention and education identifying risk and protective factors
(Fine & Kotelchuck, 2010). This perspective acknowledges throughout the
developmental trajectory, that some contexts are fixed or hard wired, and others contexts
are highly flexible or plastic and amenable to change. The life course perspective fits
well in the study of CHD as many of the contexts are both fixed and plastic occurring
along a developmental trajectory. Although this study was cross sectional, the data
provided various points in the periconceptual timeframe and throughout the pregnancy to
evaluate the relationships to CHD. The life course model recognizes the epigenetic
nature of diseases and appreciates how today’s experiences and exposures determines
tomorrow’s health. Those health trajectories are particularly affected during critical or
sensitive periods (timing) and the broader environment - biologic, physical, and social
contexts – significantly affects the ability to be healthy (environment) (Kotelchuck,
2011).
A brief description of the proposed life course perspective is presented to explain
the complex and overlapping relationships of maternal contexts to infant birth outcomes
through the developmental trajectory of periconception to birth (Figure 1). The maternal
contexts are divided into three contexts; biologic (known genetic causes associated with
CHD, age, race, chronic health conditions (CHC), family history of CHD), physical
(obesity, ETOH/drug use, cigarette use, medication/vitamin use, type of water
consumed), and social contexts (socioeconomic status (SES), occupation, education
level). The maternal contexts include fixed and modifiable factors of the maternal

12
environment or context both in the periconceptual phase and throughout pregnancy. It is
understood that some contexts are unable to be changed such as the genetic contexts, and
some contexts are amenable to change directly by choice of the mother such as the
behavioral contexts. The social contexts have some ability for change in this model.
However, some of the variables are influenced by a combination of maternal choices and
a community level influence as well. The purpose of this study was to explore the
relationships of select maternal variables to the type of CHD, birth weight and gestational
age in infants born with CHD participating in the WPCR using a life course perspective.
The hypotheses evaluated were:
Hypotheses
Hypotheses 1: Multiple maternal risk factors of biologic (known genetic causes
associated with CHD, age, race, chronic health conditions, family history of CHD),
physical (history of obesity, use of alcohol, drugs, cigarettes, medication/vitamin use, and
type of water consumed), and social variables (SES, occupation, education level)
influence the risk of complex CHD.
Hypothesis 2: Multiple maternal risk factors (biologic, physical, social) influence the
risk of low birth weight or early gestational age in the infants born with CHDs.
Definition of Terms
Maternal Contexts
Maternal contextual factors are the biologic, physical and social contexts specific
to the mothers of infants born with CHD. Maternal biologic context variables studied
include: known genetic causes associated with CHD, maternal age, race, history of
chronic health conditions, and family history of CHD.
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Biologic: Biologic maternal context variables are the maternal variables which are
inherent only to the mother and are not modifiable prior to or during the pregnancy. The
biologic variables being studied include: Known genetic causes associated with CHD,
maternal age, race, history of chronic health conditions, and family history of CHD.


Known Genetic Causes Associated with CHD: There is a higher prevalence of
CHD associated with specific syndromes or genetic abnormalities. In these
syndromes the type of CHD is sporadic if present, degree of severity, and is
related to the heterogeneous nature of CHD (Huang, Liu, Sun, Lv, Du, & Fan,
2010).

Age: Age is the part of life from birth to a given time. An individual's development
measured in terms of the years requisite for like development of an average individual
(Merriam-Webster Medical Dictionary, 2012).


Race: Race is based on the premise of physical and biological differences,
whereas ethnicity is based upon behavioral and cultural differences of groups with
no biological underpinnings and can be sometimes mistakenly used
interchangeably. Race is defined as a self-identification data item in which
respondents choose the race or races with which they most closely identify
(Federal Office of Management and Budget, 2000).



Chronic health conditions: A chronic health conditions lasts longer than 3 - 6
months, is biologically based, has a significant impact on the life of a person, and
requires more than usual access to healthcare services for support (The Council
for Children and Adolescents with Chronic Health Conditions, 2005). Maternal
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hypertension, diabetes, and epilepsy and mood disorders have been associated
with greater risk for CHD (Liu et al., 2013).


Family history of CHD: Having a first degree relative with a structural form of
CHD increases risk for CHD in offspring (Bentham & Bhattacharya, 2008; Clark,
1996). Maternal history of CHD was significant risk factors for CHD in their
infants (Liu et al., 2013).
Physical: Maternal physical context variables are variables which are modifiable

behaviors of the mother prior to or during the pregnancy. The maternal physical
variables studied include: History of obesity, ETOH and /or drug use, cigarette use,
medication and/or vitamin use, and type of water consumed.


Obesity: Obesity is a condition that is characterized by excessive accumulation
and storage of fat in the body and is indicated by a body mass index of 30 or
greater (CDC, 2012) A normal range for BMI is 18.5-24.9 (NIH, 2014).



Drug/alcohol use: Alcohol and drug use is defined as consumption of alcoholic
beverages including beer, wine, and spirits and/or illicit drugs on a weekly basis
(Strandberg-Larson at al., 2011).



Cigarette use: Cigarette or tobacco use is defined as smoking/using of
cigarettes/tobacco products on a daily basis (Karatza et al., 2011).



Medication/vitamin use: According to the Food, Drug, and Cosmetic Act (2002)
a drug is a substance recognized in an official pharmacopoeia or formulary; or a
substance intended for use in the diagnosis, cure, mitigation, treatment, or
prevention of disease; a substance other than food intended to affect the structure

Figure 1. Life course Conceptual Framework
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or function of the body; or a substance intended for use as a component of a
medicine but not a device or a component, part, or accessory of a device.


Type of water consumed: Ingesting contaminated drinking water has been
associated with increased risks for birth defects (Watson, Jacobson, Williams,
Howard & DeSesso, 2006). Contaminated drinking water is a growing concern
in many industrialized and industrializing nations due to increased population
demands for products.
Social: Social maternal context variables are the social influences or immediate

community variables of the mother. The social contexts can be influenced by maternal
choice and/or sociological influences of the immediate community surrounding these
mothers. The social maternal variables studied include: maternal socioeconomic status,
occupation, and education level.


Socioeconomic Status: Socioeconomic status is a combination of income level,
educational level, and community income level (Luo, Wilkins, Kramer, &
FIHSG, 2006).



Occupation: Occupation can include paid and unpaid work history, job tasks,
type of industry, and materials handled or machinery used (Shaw, Nelson,
Iovannisci, Finnell, & Lammer, 2003).



Educational Level: Educational level is the amount of school achieved/
completed by the mother (Alverson, Strickland, Gilboa, & Correa, 2011).
Infant Outcomes: Infant outcomes are the birth outcomes of the infant born

with CHD. Infant birth outcomes being studied include: type of CHD either simple or
complex, birth weight, and gestational age. It was believed that the more complex the
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CHD the greater the risk for prematurity and low birth weight would be observed. In the
literature, CHD has been associated with small for gestational age and lower birth
weights (Malik, Cleves, Zhao, Hobbs & NBDS, 2007).


Type of CHD (simple or complex): CHD can be classified in many different
methods including anatomical classifications or cyanotic heart disease (Kornosky
& Salihu, 2008; Mitchell, Korones, & Berendes, 1971), pathogenic
classifications (Botto & Correa, 2003; Ferencz et al., 1997; Clark, 1996; Marelli,
Mackie, Ionescu-Ittu, Rahme & Pilote, 2007), structurally significant verses
insignificant (Ferencz et al., 1997; Grech 1999; Pradat, Francannet, Harris &
Robert, 2003; Teun van der Bom et al., 2011), with or without genetic mutation
(Lin & Ardinger, 2005; Pradat, Francannet, Harris & Robert, 2003) or surgical
classifications (Jacobs et. al. 2007). In this study CHD was separated into either
simple or complex and was identified from ICD-9 codes. Simple CHD consisted
of single diagnoses of CHD, and/or did not cause significant cyanosis, and/or did
not require immediate hospitalization or surgical intervention within the first year
of life. Complex CHD consisted of multiple CHD diagnoses, and/or were
cyanotic lesions, and/or required hospitalization or surgical intervention within
the first year of life. Based upon past research simple CHD consists of isolated
CHD including; atrial septal defect (ASD), ventricular septal defect (VSD),
pulmonary stenosis (PS), aortic stenosis (AS), bicuspid aortic valve (BAV),
coarctation of the aorta (COA) and mitral valve (MV) disease. Complex CHD
consists of single or multiple diagnosis including; Tetralogy of Fallot (TET),
atrioventriculoseptal defect (AVSD), transposition of the great arteries (TGA),
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pulmonary atresia (PA), hypoplastic left heart syndrome (HLHS), and
univentricular heart disease or variants including multiple lesions.


Birth Weight: Weight at birth is defined as pounds and ounces or kilograms.
Birth weight can be categorized into very low (<1500g), moderately low (15002499g), and normal birth weight (2500g+) (Nembhard, Salemi, Loscalzo, Wang,
& Hauser, 2009).



Gestational Age: Gestational age is defined as the time from conception until
birth or the number of weeks from the first day of the mother's last menstrual
period (LMP) until the birth (Engle, 2004). Gestational ages are assessed by the
date of the LMP and by physical exam using the Dubowitz/Ballard examination
score (Engle, 2004). By definition, moderate to late preterm is considered < 37
weeks gestation, very preterm (28 to < 32 week) and extremely preterm (< 28
weeks) (WHO, 2013).

Time: The trajectory of time includes the periods of periconception and includes all time
up until the birth of the child with CHD.
Methods
This study was an exploratory secondary analysis of the maternal biologic,
physical, and social contexts and their relationships to gestational age, birth weight and
types of CHD in these infants. Using a Life course model (Fine & Kotelchuck, 2010) to
guide this research, associations or relationships between the maternal variables and
greater risk for complex CHD in their infants were assessed separating CHD into either
simple or complex CHD. Descriptive analyses provided correlations and identification of
relationships of the maternal context variables to the birth outcomes of the infants. From
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these analyses logistic and multiple regression were used to test the hypotheses and
answer the research questions posed. Approval was obtained from Children’s Hospital of
Wisconsin (CHW) Internal review Board as an exempt study (Appendix E) as consent to
participate was previously provided in the original study conducted at CHW and no
patient contact was required. All data provided to the investigator were de-identified and
maintained or accessed on a secure computer.
As the WPCR was adapted from the BWIS, a modified approach from the BWIS
to categorize the simple and complex CHD was utilized. The dependent variable of
simple or complex CHD was derived from multiple classification techniques (Calzolari et
al., 2003; Hoffman, & Kaplan, 2002; Warnes, et al., 2001; Ferencz et al., 1997) used to
categorize severity of CHD in both children and adults. Many struggle to classify CHD as
there are countless forms of severity and CHD has a heterogeneous nature. Some forms
of CHD may not be symptomatic or identified until later in life causing no health
changes, whereas other forms of CHD can be life threatening and cause many health
changes throughout one’s life with detrimental effects.
In the WPCR all CHD was diagnosed before 2 years of life by a pediatric
cardiologist identifying various severity levels of CHD, some requiring interventions and
other CHD spontaneously resolving. Therefore the various severity levels in the WPCR
should be well represented over the last 10 years. In the BWIS the researchers
categorized etiologic CHD into primary and secondary cardiogenesis defects and from
the exposures, demographic information and medical history of the parents identified
significant risk factors of CHD. In the BWIS they classified the CHD into six “pure”
diagnoses and used severity ratings based upon echo results to assign case severity for
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pulmonary stenosis, aortic stenosis, ventricular septal defect, and bicuspid aortic valve
using echo. As an adequate control group is not available for use within the WPCR, to
replicate the BWIS, and compare normal infants to infants with CHD, the independent
variable of CHD was divided into either simple or complex CHD. Other studies have
categorized CHD into simple, moderate and complex CHD (Calzolari et al., 2003;
Hoffman and Kaplan, 2002; Warnes et al., 2001) to describe the incidence and outcomes
of each type of CHD. As many of the simple CHD can go undetected it is difficult to
determine precise incidence and possible risk factors.
It was hypothesized that the multiple maternal risk factors of biologic (known
genetic causes associated with CHD, age, race, chronic health conditions, family history
of CHD), physical (history of obesity, use of alcohol, drugs, cigarettes,
medication/vitamin use, and type of water consumed), and social variables (SES,
occupation, education level) would influence the risk of simple or complex CHD. A
variety of statistical analyses including descriptive statistics, correlations, and regressions
were used. For hypothesis 1; a logistic regression analysis was undertaken and for
hypothesis 2 a multiple hierarchical was proposed and performed.
It is recognized that the data in the WPCR were collected prior the development
of this study and may have limitations but also has several benefits. A significant benefit
for using the data within the WPCR database was the large sample size that was collected
over a decade. Pre-existing datasets may be useful to address hypotheses and research
questions of interest and can provide a practical component to the researcher to advance
science (Campbell, 2007). This dataset allowed investigation of the maternal risk factors
not previously examined in this database. The WPCR database has been active for well
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over a decade providing a robust sample which may not be available to most novice
researchers. This sample provided a collection of maternal and infant variables including
demographic, socioeconomic, personal health history and environmental exposure history
in families affect by CHD. Using a large data can also have limitation such as
unfamiliarity with the methods of storage, accessibility of the variables in print and
electronic forms and knowledge of the maintenance practices (Aponte, 2010). Thus care
should be applied in the results of the studies performed. The researcher must be cautious
in the implications for inference of causal relationships between these variables in the
development of CHD, as specificity and dose response cannot be elicited from the
measures used in the WPCR.
A limitation of the registry was lack of a robust control group which precluded the
investigation of factors related to CHD. The families in the small control group were
systematically different than the families in the CHD sample. First the children in the
control group were significantly older than the CHD sample; most of the children were
10 years older than those in the CHD sample. Second the recruitment of the control group
was initiated in 2006 well after the original study began in 2000. Recall for
questionnaires would be greatly compromised by the time interval as the comparison
children were over two years of age. However, the large sample of mothers and their
infants with CHD was useful in the investigation of the three outcomes, type of CHD,
birth weight and gestational age. The WPCR was appropriate for this secondary analysis
because of sample was large, the data were accessible and there was sufficient variability
within the data to address the proposed hypothesis (Aponte, 2010).
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Although the data were not collected with a specific research question in mind,
the WPCR was designed to allow researchers and clinicians access to temporal,
environmental, familial, and genetic data to explore relationships of potential causative
factors of CHD which is congruent with my specific aim. The researcher must be
cognizant of ethical and practical concerns when determining fit of the data to their
research questions (Campbell, 2007). High impact questions, such as substance use,
comprehensive social and medical histories, and data containing infant or child
information may be out of reach of most researchers due to time or financial constraints,
but can be probed by secondary analysis that may allow for discovery of problems or
concerns within the original research (Smith et al., 2010). Understanding problem areas
in the primary research may allow for adjustments of future research targeting a new and
more focused research question.
Study Summary
There is undeniable evidence that CHD is the most prominent and costly birth
defect in the United States. CHD significantly contributes to the infant, child, and adult
morbidity and mortality rates and places substantial financial burdens upon the
individuals with CHD, medical providers and intuitions, and governmental resources
necessary to support treatment and care for this chronic health condition. Emphasis on
primary and secondary prevention has been stressed and recommendations are necessary
in the education to decrease risk factors for CHD of young child bearing aged individuals
both male and female.
A review of literature was performed to gain a greater understanding and
identification of the maternal risk factors for all CHD. In this review it was
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acknowledged that the literature was separated into the various maternal risk factors and
did not provide a comprehensive review for all the maternal context variables measured
in this study. Small samples with methodological flaws and inability to accurately
measure the variables relationships with greater risk for complex CHD were identified in
this process. Only one study was found addressing the risk factors for simple verses
complex CHD, a gap this study was designed to address. It was also recognized that the
genetic influence toward CHD must be elaborated separately to best appreciate the
influence on CHD development.
Nursing is a leader in prevention, education, and care of humans with various
diagnoses including complex CHD. Research focusing on maternal context variables and
risk for complex forms of CHD may provide knowledge for women of child bearing age
to the known environmental risk factors associated with CHD and aid in early detection
of complex CHD if exposed. Timing of an intervention is of essence as the fetal heart is
formed within the first trimester of pregnancy, most often when the woman is unaware of
the pregnancy. Education or knowledge development of young child bearing individuals
during the time before conception may be key for avoidance of specific environmental
exposures which may enhance the risk of giving birth to a child with complex forms of
CHD.
With a greater understanding and appreciation of the mechanisms associated with
gene-environment interactions during the processes prior to and during cardiogenesis (the
development of the heart in the embryo) researchers and clinicians can facilitate new
interventions in practice and research questions. These innovative ideas and practice
changes may assist in decreasing the incidence of complex CHD. Decreasing known
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environmental exposures and increasing positive heath care practices may help reduce the
number of children born with all forms of CHD. Data was collected with a goal to
provide the ability to test for relationships amongst the genetic, epidemiologic, temporal
from the participants. From these results, it is hoped that identification of possible
etiologic sources for CHD development in the infant is discovered. It is anticipated that
this study will provide a greater understanding of the maternal contexts associated with
complex CHD, birth weight and gestational age in these infants.
Manuscripts
This dissertation is composed of an introductory chapter, three manuscripts
(Chapters 2, 3, 4) and a chapter discussing the implication of the findings (Chapter 5). A
review of literature is provided in chapter two and includes the first manuscript titled
“Association of Maternal Risk Factors and Congenital Heart Defects”. This manuscript
synthesizes maternal risk factors for giving birth to an infant with CHD, gaps in the
literature and implications for clinical care. Chapter three is comprised of the second
manuscript titled “Understanding Genetics and Pediatric Cardiac Health”. This
manuscript provides a review of known genetic factors on risk of CHD formation in the
infant. Future implications for study and practice are provided in this manuscript.
Chapter four is the third manuscript titled, “Maternal Health and Infants Born with
Congenital Heart Disease: A Secondary analysis of the WPCR”. In this manuscript the
methods and results as well as study limitations are presented. Chapter five provides an
in-depth discussion of the results including implications for practice and policy.
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CHAPTER 2
Chapter Introduction
The purpose of this chapter is to provide a review of the literature related to the
maternal context factors associated with CHD. This review was conducted to obtain a
general understanding of the maternal risk factors for all CHD. The focus of this chapter
will be the maternal environmental risk factors for CHD development in the infant. Using
a life course perspective the maternal contexts will be arranged in a biologic, physical
and social construct. This chapter is comprised of a systematic review in the format of an
article to be submitted for journal submission. The referencing style of this target journal
will be applied in this manuscript.
Manuscript 1: Association of Maternal Risk Factors and Congenital Heart Defects:
State of the Science
Abstract
Aim and objective. Guided by the life course model, this review summarizes the state of
the science about the contextual maternal risk factors for giving birth to an infant with
congenital heart defect (CHD).
Background. CHD is the most prevalent birth defects worldwide occurring in
approximately every 6-8 per 1,000 live births. Only 10-15% of the CHD etiology is
known, and are primarily genetic syndromes and disorders. The remaining 85-90% of
CHD is thought be influenced by the environment.
Design. Systematic literature review using PRISMA guidelines.
Method. Studies included in this review were identified through a Medline search which
included studies published from 2008-2013. The articles (N=39) were analyzed to
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identify the contextual maternal risk factors for CHD and were categorized into biologic,
physical, and social environments using a life course perspective.
Results. Multiple maternal risk factors for CHD development in the infant were
identified in the maternal biologic, physical and social environments.
Discussion. Women of childbearing age have the ability to optimize their health prior to
pregnancy, thus reducing risk for CHD in their infants. Identification and discussion of
risk factors is critical in early pre conceptual and prenatal care.
Conclusions. This review highlighted the contextual maternal risk factors for CHD in
the pre-and inter-conceptual timeframes. There are many complex genetic and
environmental interactions which influence CHD development. Further research is
needed to better understand the risk factors for CHD.
Relevance and clinical practice. The contextual maternal risk factors for CHD in the
pre- and inter-conception timeframes were discussed and described allowing nurses and
healthcare professionals the ability to provide education to their families of childbearing
age thus reducing risk for having an infant with CHD.
Key Words: CHD, maternal risk factors, pre-conception, inter-conception, life course
model.
Introduction
Congenital heart defects (CHD) are the most prevalent birth defects worldwide
occurring in approximately every 6-8 per 1,000 live births (Hoffman & Kaplan, 2002).
CHD is one of the leading causes for infant morbidity and mortality, with only 10% to
15% of the CHD etiologies understood. Of all CHD, 5% to 10% can be attributed to a
chromosomal abnormality, 3% to 5% are linked to single gene defects, and
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approximately 2% are a result of known environmental factors (Clark, 2001). For the
remaining 85% to 90% of CHD cases, the etiologies remain unknown.
Although there has been extensive research on genetic risk factors for CHD, there
is much less understanding of maternal environmental factors. Past and present research
continues to support the gene-environment interaction theory (Nora, 1968), in which both
genetic predisposition and environmental factors are responsible for the majority of CHD
(Mone et al. 2004, Lin & Ardinger, 2005, Hobbs et al. 2010). Some researchers have
focused on specific disease processes such as maternal diabetes (Ferencz et al. 1997, ,
Lisowski et al. 2010), lifestyle choices such as cigarette smoking (Grewel et al. 2008,
Hackshaw et al. 2011), or other exposures such as chemical exposures within the home or
workplace (Watson et al. 2006) for increased risk of CHDs. Although there is some
evidence there are exposures that are related to CHD development such as rubella,
thalidomide, cigarette, drug, and ETOH during early pregnancy (Brent, 2004) the exact
mechanism is not well understood.
Some researchers have focused on specific exposures and the development of
CHD throughout pregnancy, for examples exposures to maternal illnesses, cigarette,
drug, and ETOH (Mone et al. 2004). A greater understanding of the critical time frames
prior to and during CHD development have been identified; the pre-conception and interconception periods (Liu et al., 2013). Researchers are now appreciating the impact of the
pre-conceptual exposures, particularly in the three months before pregnancy and risk for
CHD development in the fetus (Jenkins et al. 2007). Several reviews specifically
addressed the nongenetic (Patel et al. 2013), non inherited (Jenkins et al. 2007), effects of
contaminated drinking water (Bove et al. 2002, Watson et al. 2006), environmental
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exposures (Thurlstrup et al. 2006) and environmental pollution (Gorinini et al. 2014) and
risks for CHD. These reviews selected specific risk factors not all with a focus on
maternal risk factors for CHD therefore the present analysis was conducted to better
understand the maternal context risk factors for CHD development. All of the reviews
acknowledged that the risk factors of CHD development require further investigation due
to several concerns such as small sample sizes, inability to perform exact measurement of
exposures, and confounding variables which may have influenced results.
A Life Course Perspective
The life course perspective uses a model that helps explain the processes of health
and disease patterns across populations and time (Fine & Kotelchuck, 2010). With the
premise that today’s choices affect tomorrow’s health (timeline), there are critical and
sensitive periods (timing), that biological, physical, and social contexts (environment) as
well as healthcare access (equity) affect the outcomes of health (Fine & Kotelchuck,
2010). These multiple trajectories have complex interactions, which over a lifetime can
be influenced in both positive and negative manners changing ones health and health
choices. As CHD is believed to be a complex multifactorial process a life course
perspective was chosen to illustrate the interactions between the contextual maternal risk
factors. The genetic syndromes and chromosomal abnormalities associated CHD were
not included in this review.
The maternal context variables have multidimensional relationships across time,
which allows for categorizing the various risk factors into these contexts. The biologic
maternal contexts are fixed and although genetically inherited, are not defined by a
specifically known gene or chromosomal abnormality associated with increased risk of
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CHD. These variables are thought to be preprogrammed or difficult to change with
lifestyle modifications and/or choices. Physical maternal contexts are categorized by the
physical influences or choices of the mothers which increase may the risk of CHD in
their infant. The physical contexts are thought to be modifiable physical choices of the
mothers such as alcohol or drug use as examples. Social maternal contexts are those
contexts influenced both by maternal choice and the sociological influences of the
immediate community surrounding these women. The social maternal contexts are
usually not easily modified or quickly changed but can assist in identifying at risk
populations.
Aim
The purpose of this review was to identify and summarize the current literature on
contextual maternal risk factors associated with giving birth to a child with CHD. The
life course perspective was used as the organizational framework used to guide this
review.
Methods
Using PRIMSA guidelines a review of literature was conducted. A search was
conducted using three databases, Medline, CINAHL, and ESBCOhost and the MESH key
terms; congenital heart defects (CHD), maternal risk factors for CHD, and congenital
birth defects. Inclusion criteria were studies published in English after 2007 that provided
evaluation of maternal risk factors for CHD. A total of 164 articles were identified – all
from Medline database. A flow diagram of the review and inclusion process is provided
(see Figure 1). To ensure the search was comprehensive the key words above were
combined with the following key terms: smoking, alcohol, substance use, educational
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status, occupation, socioeconomic status, and lifestyle which elicited an additional 11
articles after duplicates and articles which were not relevant were excluded. Included in
the review were articles were obtained from reference lists of studies from the original
search or reviews which included seminal research or articles published after 2007. Case
control, retrospective and prospective studies, population studies and meta-analyses were
included in the final analysis. Two articles published in 2004 were retained for the review
as there were limited findings in illicit drugs and water consumption. A total of 39
articles were retained for this review. In Tables 1, 2, and 3 the biologic, physical and
social maternal contexts variables are summarized into the categories, author, description
of the study and findings, specifically prevalence if provided and odds ratios/risk ratios
prevalence showing relationships of these variables to risk for CHD development.
Studies are presented by topic and alphabetically by first author.
Results
Biologic maternal contexts.
Maternal age. Analyses from several large congenital defect registries within the
United States and Canada have identified an increased risk for infant CHD if their mother
was > 35-40 years of age (Long et al. 2010, Miller et al. 2011, Liu et al. 2013). The
prevalence of CHD in advanced maternal age (>35 years) was found to be about twice
the normal prevalence of CHD (6-8/1,000 live births) in these studies. An as association
of advanced maternal age (>35 years) and specific types of complex CHD in the infants
such as Tetralogy of Fallot, truncus arteriosus, coarctation of the aorta, and transposition
of the great vessels were identified in two large population studies in Atlanta and Texas
(Long et al. 2010, Miller et al. 2011).
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Maternal race. Race is based on the premise of physical and biological
differences, whereas ethnicity is based upon behavioral and cultural differences of groups
with no biological underpinnings. Race is defined as a self-identification data item in
which respondents choose the race or races with which they most closely identify
(Federal Office of Management and Budget, 2000). It is important to note in some of the
studies reviewed race and ethnicity were used interchangeable.
Greater CHD prevalence was found in non-Hispanic White women in three
studies (CDC 2010, Mangones et al. 2010, Miller et al., 2010). Although, these studies
found greater prevalence in non-Hispanic white (NHW) women overall, Nembhard et al.
(2010) reported similar rates of CHD in NHW, non-Hispanic-Black (NHB) women and
Hispanic women in their retrospective study using the Florida Birth Defects data. In the
CDC’s report (2010) it is important to note, the rates of CHD prevalence was less in
NHB women. However, the mortality rates in term infants in this group were higher than
the NHW group (1.5 per 10,000 compared to 1.3 per 10,000).
The research reviewed provided evidence of racial/ethnic differences in rates of
CHD with predominance in NHW women. These studies reported these populations had
higher numbers of white women and less racial diversity which may provide an
explanation for their findings. It is also important to recognize the differences in birth
outcomes among the groups and higher rates of mortality in the NHB women. Although
higher prevalence of CHD is found in NHW women, their birth outcomes are better than
NHB, and Hispanic women.
Maternal chronic health conditions. Maternal chronic health conditions can
encompass a multitude of disease processes and several were associated with increased
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risk for CHD development in the fetus. Febrile and viral illnesses were associated with
3.4 to 5 fold increased risk of CHD, particularly right sided obstructive lesions, when the
mother has encountered this illness within three months prior pregnancy or within the
first trimester in the infants in the Baltimore Washington Infant Study (Oster et al. 2011).
Luteijn and Dolk (2013) found 1.5-2.5 fold risk for CHD if the mother had history of
influenza within the first trimester of pregnancy. The use of antibiotics and
antihypertensives (OR 2.6-3) in the first trimester were associated with increased risk of
CHD (Zen et al. 2011).
Maternal diabetes was reported to increase risk of CHD in infants four times that
of normal infants (Liu et al. 2013). Persistent truncus arteriosus, transposition of the
great vessels, conotruncal abnormalities and single ventricle physiology were particularly
likely to occur. These infants were found to have a two to 18 fold increased risk if the
mother had poorly controlled gestational diabetes in the first trimester of pregnancy. Comorbid conditions such as connective tissue disorders (3.01; 95%, 2.23-4.06),
hypertension (OR 1.81; 1.61-2.03), and obesity (OR 1.15-1.3) have also been associated
with greater risk of CHD in the infant (Lui et al. 2013, Mills et al. 2010, Stochard et al.
2011).
Family history of CHD. The risk of having an infant with CHD was found to be
2-4% greater if related to a first degree relative with known CHD (Fesslova et al. 2011,
Fung et al. 2013, Hinton et al. 2007). If more than one family member was diagnosed
with a CHD, the concordance rate was higher still (55%) in the study of probands
(individual affected by a disorder) with HLHS, reporting an almost 4 fold increase of
CHD in first degree relatives (Hinton et al. 2007). Swaby et al., (2011) showed similar
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findings in their study of increased heritability of varying forms of CHD in relatives of
adults with known 22q11.2 deletion syndrome (OR 4.43-5.88). With the greatest risk (RR
2.68-48.6) found for heritable CHD in first relatives for variable forms was found in a
large Danish cohort study (Øyen et al. 2009).
Physical maternal contexts.
Maternal obesity. Obesity is a chronic condition of great public health concern
in all ages. However, in pregnancy obesity has been associated with poor birth outcomes
and greater risk for congenital birth defects including CHD (Arias & Brown, 2010,
Hobbs et al. 2010, Mills et al. 2010, Stothard et al. 2011, Baardman, et al. 2012).
Maternal obesity is a factor found to have a small to moderate risk (OR 1.1-1.43) for
CHD development in the infant (Arias & Brown, 2010, Hobbs et al. 2010, Mills et al.
2010, Stothard et al. 2011, Baardman, et al. 2012). Some investigators found an
associated increased risk for CHD development with obesity and smoking status (Hobbs
et al. 2010, Baardman et al. 2012), which may demonstrate a change in the genetic
pathways of the mother when altered by smoking status. Although obesity is a growing
epidemic across the United States in all ages, data demonstrate obese women have greater
complications during pregnancy than do normal weight women (Mills et al. 2010,
Stothard et al. 2011).
Maternal substance use. Maternal history of alcohol use was identified in four
studies as a modest risk for CHD development in the infant (OR 1.1-2.4). These studies
found higher rates of conotruncal (disorders of the outflow tract) CHDs (OR 1.3-1.9)
(Grewel et al., 2008, Strandberg-Larsen et al. 2010, Zen et al. 2011). Strandberg-Larens
et al.’s (2010) Danish study did not find an associated increased risk for CHD with low to

34
moderate alcohol consumption. No significant risk for CHD was reported when binge
drinking was present. However, Mateja et al. reported that binge drinking in the United
States was associated with a two fold increase of CHD development. And when binge
drinking and smoking was present in the three months prior pregnancy the risk for CHD
development was significant (aOR 9.45 and 12.65).
Illicit drug use is a public health concern affecting all ages. Approximately 4% of
pregnant women in the United States use illicit drugs (Substance Abuse and Mental
Health Administration, 2007). Williams et al. (2004) found a twofold increased risk for
VSD when the mother had history of marijuana use.
Maternal tobacco use is associated with low birth weight, prematurity, risk for
stillbirth, and risk for congenital malformations (Malik et al. 2008). Six studies were
found in which a modest association with increased risk for CHD in the infant when
maternal smoking was present (OR 1.5-2.1) (Malik et al. 2008, Hobbs et al. 2010,
Alverson et al. 2011, Patel et al. 2012, Lee & Lupo, 2013).
Maternal medication/vitamin use. Folic acid has been recommended to
decrease risk of neural tube defects and has been shown to decrease the risk of CHD by
18% -38%, particularly VSDs in a large European study (Van Beynum et al. 2010).
However, vitamin E was found to increase the risk of CHD when supplemented and
consumed at high levels in the mothers diet (Smedts et al. 2009). Prescription
medications are complicated to prescribe and to know if it is safe to use during pregnancy
as there are limited studies and ability to test safely in humans. Alwan et al. (2010) found
an increased risk for left ventricular outflow tract CHD when there was maternal history
of buproprion use in the first trimester of pregnancy. And the use of antibiotics and
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antihypertensive medications during the first trimester was associated with a 2.6-3 fold
increased risk for CHD formation in the fetus in Brazil (Zen et al. 2011).
Maternal drinking water. Trichoroethylene (TCE) is a metal degreasing agent,
previously used as an anesthetic, and a common persistent drinking water contaminant
known to be a selective cardiac teratogen (Yauck et al. 2004). In a large case control
study in Milwaukee, Wisconsin a 6 fold increased risk in older women (≥ 38 years) was
found when exposed to TCE (Yauck et al. 2004). Whereas in Lithuania exposure to
trihalomethane (THM) a water disinfection agent, was found to have a 1.7 fold increased
risk for CHD if exposed to bromodichlormethane (BDCM) a common TMH, in the first
trimester of pregnancy (Grazuleviciene et al. 2013).
Social maternal contexts.
Maternal SES. In a large population based study in the United States, low
maternal income levels were associated with poorer birth outcomes, lower birth weight,
prematurity or morbidity and a modest increased risk for CHD (Malik et al. 2007).
Carmichael et al.’s (2009) case control study in California found no increased risk for
CHD in lower income and educational level of the parents. In Lithuania, a lower
education and lower status occupations was associated with a modest increased risk (OR
1.48-3.43) for CHD in the infant (Kučienė and Dulskienė, 2009).
Maternal occupation. Occupational exposure to chemicals, air pollution, and
hazardous situations can affect the woman and unborn child’s health as has been
associated with increased risk for CHD (Lin et al. 2012). Three European teams in Italy
(Cresci et al. 2013), Netherlands (Snijder et al. 2012), and Russia (Vaktskjold et al. 2011)
all found a moderate increased risk for CHD development in occupational exposure to
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solvents (OR 1.2-2.6). Maternal exposure within the first trimester or one month prior to
pregnancy to any solvents and chlorinated solvents were found to increase risk of VSD,
aortic valve disorders, D-TGA, right ventricular outflow tract (RVOTO) disorders, and
pulmonary stenosis (Gilboa et al. 2012). In the National Birth Defects Prevention Study
(Lin et al., 2012), nurses, janitors, scientists and engineers were found to have a
moderately higher risk for conotruncal CHD (OR 1.35-3.48).
Maternal education. Educational attainment has been associated with choice of
life partner, smoking and drinking practices, and employment and has been shown to
affect birth outcomes. The educational level of the mother was not significantly related
to increased risk of CHD in two large population studies in the United States (Carmichael
et al. 2009, Malik et al. 2009). However, a moderate risk for CHD was found in low to
moderate levels of maternal education in Kučienė and Dulskienė’s (2009) study in
epidemiologic study in Kaunas Lithuania (OR 3.43, 95%, CI 1.54-7.64).
Discussion
Through this review, the biologic, physical and social maternal risk factors for
CHD were identified and presented to provide a comprehensive maternal review of risk
for CHD development. Several maternal risk factors for CHD (advanced age, CHC, FH
of CHD and alcohol use) were identified. However, respective of the research, often it
revealed conflicting results and/or weak associations to CHD development (race, obesity,
smoking, medications, water, SES, occupation, education) were present, similar to past
reviews. Only one study was identified in this review regarding substance use (Williams
et al. 2004).
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CHD is a multifactorial process with multiple sources for alteration of fetal
development. Timing and sensitive periods in cardiac development can vary. The critical
time frames for CHD development were identified as pre- and inter-conception. It was
also recognized that there are multiple exposures and other risk factors which can be
difficult to pin point direct causative factors for CHD development. This review
identified binge drinking in the pre-conception timeframe increased the risk 12 fold for
CHD development (Mateja et al. 2012). Although current medical technology has
allowed many infants, children, and adults to survive and live productive lives in society
today, identification and elimination of risk factors for CHD development is critical to
reduce the number of infants being born with this life threatening and life altering
disease.
Validity and Limitations of the Review
A review of the literature describing risk, incidence and prevalence of CHD
throughout the world identified several maternal risk factors for CHD. However, many of
the maternal context variables were not measured or defined sufficiently to determine if
there is a significant risk for giving birth to an infant with CHD. Most studies in this
review were case control, retrospective studies reviewing large amounts of registry data
some of which reported prevalence of CHD by types. Historical recollection and
reporting of exposure or use of a substance or situation was a concern for many of the
reviewed studies. Better surveillance practices during these critical times for exposures
may help identify and better isolate exposures. Another major concern of the current
research reviewed is the ability to obtain precise measurements of dose exposures, for
example occupational hazards, contaminated water and environmental influences. It was
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difficult to ensure accuracy of the data collected from the mothers, as recall bias and
reporting errors were acknowledged. It is acknowledged by most researchers that the
confounding variables affect many of the study variables and cannot provide conclusive
causal evidence linking a specific variable to CHD. However, it is important to respect
the relationships supported and identified in these research studies to guide future
research in these areas. Inspection of the findings from many of the studies showed
increased risks of CHD with various exposures or demographic variables in comparison
to the general populations.
Most investigators encouraged further research to better isolate and identify
significant relationships among variables, targeting modifiable life choices, or primary
prevention techniques to decrease risk of CHD in the infant. These investigators
recognized the complex interactions and inability to easily separate between variables
and identify significant risk factors. It is likely impossible to isolate each maternal
variable and determine cause for CHD, but studies exploring the pre- and interconceptual timeframes and maternal exposures may provide evidence for increased risk
that can be intervened upon. As the life course perspective describes health, it is
important to appreciate the multiple trajectories in one’s life; today’s choices affect
tomorrow’s health.
Relevance to Clinical Care
Nurses are at the frontline of patient care delivery. Greater understanding of
maternal risk factors for CHD development is key to reduce the most prevalent birth
defect worldwide. By understanding the complex nature of CHD, and the risk factors
associated, nurses can begin to identify women at risk prior to pregnancy. A thorough
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knowledge of the maternal risk factors, for example the modifiable lifestyle choices, such
as drug, alcohol, tobacco, and maintenance of weight, can be indentified and discussed
with adolescent girls and women of child bearing age decreasing their risk of CHD in
future pregnancies. These at risk women may benefit from close monitoring, fetal
echocardiographic screening or genetic counseling prompted by their HCPs. Early
morbidity and mortality can be prevented and decreased in infants with CHD if early
identification and treatment is provided (Botto & Correa, 2003; Masmoudi & Massin,
2008). Women with fetuses found to have CHD can benefit from prenatal counseling of
the options for giving birth at institutions equipped for the infant with CHD, surgical
interventions or palliative procedures specific to the type of CHD or preparation for end
of life considerations for the infant born with complex CHD.
Nurses can discuss in depth the known risk factors for CHD with women who
have chronic conditions and necessary management of the condition. For example, early
identification and screening of diabetes in pregnancy would allow for close monitoring
and tight control of blood sugars of diabetic mothers, thus decreasing their risk of CHD in
the developing infant. In the pre-conception time frames, medication review and
clarification of safety of medication should be discussed for risk of CHD to allow for
changes in care management if a pregnancy is being considered.
Central to women’s health is screening for drug, alcohol, and tobacco use from
early adolescence through childbearing years and discussing the risks associated for birth
defects, particularly CHD. Prevention programs are needed to address these risk factors
throughout the community to have a positive impact on families planning a pregnancy.
Nurses can provide education of the considerable risk of CHD associated with binge
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drinking in the pre-conceptual timeframes. Because almost half of pregnancies in the US
are unplanned, women’s health care providers need to aggressively address these issues
in all well-women’s care. Pregnancies occurring when women are in optimal health may
help ameliorate these conditions. Early prenatal care in primary care settings is also
crucial to identify the at risk women to provide the necessary interventions if CHD is
identified. These initiatives can be used by multiple health care providers addressing
health of the family in pediatric and community settings.
Conclusion
Through this review of maternal biologic, physical and social contexts associated
with risk of CHD, identification of the associated risk factors for CHD was clarified.
There were studies in which types of CHD and associated risk factors in comparison the
general public were discussed. But, no studies other than the BWIS identified risk
between types of CHD. Although there was conflicting results among some of the
contextual variables (race, obesity, smoking, medications, water, SES, occupation,
education) the risk for CHD was identified. Development of future research in these
areas is necessary to not only identify potential etiological sources, but to identify
families at greater risk for having a child with CHD. Nurses and healthcare providers
require an understanding of the processes and mechanisms associated with CHD to
decrease risk of CHD development. Although the etiology of CHD remains a mystery,
scientists, nurses, and researchers continue to study potential causes appreciating and
respecting the multifactorial nature of this disease.
An in depth history of biologic, physical, and social exposures of women of child
bearing age should be performed to assist in identification for risk of CHD. Prompt
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identification of the mother and fetus with CHD allows time for decisions, treatment, and
planning to avoid adverse outcomes. Research in the environment exposures experienced
among child bearing adults may provide evidence for the identification of risk factors for
CHD, allowing for genetic counseling and targeting of resources for the affected
individuals to maximize growth and development of the infant born. There are multiple
known maternal risk factors for CHD development in the inter- and pre-conception
periods in a woman’s life which requires greater study. Researchers agreed further
investigation is necessary to gain understanding of the etiological sources of CHD.
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Table 1
Biologic Maternal Contexts
Maternal
Article
context
Age

Race

Description

Liu et al. 2013

Population based cohort study (n=2,278,838 maternal infant pairs, 26,488
infants with CHD) in Canada from 2002-2010. Several chronic maternal
medical conditions, including: diabetes, hypertension, connective tissue
disorders, and congenital heart disease, showed an increased risk of CHD in the
offspring.

Long et al. 2010

Large population birth defect registry- Texas 1999-2004 2,208,758 births,
prevalence rates TA-0.76, dTGA-2.98, TOF-3.40/ 10,000 births. Advanced
maternal age >35 years showed a linear increase to risk of giving birth to a child
with non-syndromic TOF, TA, d-TGA*.

Miller et al. 2011

Large population birth defects registry-Metropolitan Atlanta Congenital Defects
Program (MACDP) case control 5,289/1,301,143. Possible association with
advanced maternal age > 35 yrs, with specific CHD phenotypes.

CDC, MMWR, 2010

Report: Infant birth/death data in US 2003-2006, neonatal mortality attributable
to CHD was 30% lower in black mothers than white mothers. In term infants,
black mothers had a 20% higher neonatal mortality rate attributed from CHD to
those of white mothers.

Mangones et al. 2010

Population study from NYS Dept of Health Vital statistics, congenital
malformations registry1992-2001, (n=2,303/235,230- 13/1000 live births.
Highest prevalence among NHW followed by NHB, then Others.

Miller et al. 2011

Large population birth defects registry-Metropolitan Atlanta Congenital Defects
Program (MACDP) case control 5,289/1,301,143. Greater prevalence in white
mothers vs. non-white mothers for CHD.

Findings: Prevalence, adjusted prevalence ratio
Odds ratio, risk ratio (values are significant, p
<0.05*, p < 0.001**)
Risk factors: Maternal age ≥ 40 yrs, aOR 1.48;
95% CI, 1.39-1.58, multi-fetal pregnancy aOR
4.53; CI, 4.28-4.80, diabetes mellitus type 1: aOR,
4.65; CI,4.13-5.24; type 2: aOR 4.12; CI, 3.694.60, hypertension aOR 1.81; CI, 1.61-2.03,
thyroid disorders aOR, 1.45; CI, 1.26-1.67, CHD
aOR 9.92; CI, 8.36-11.8, systemic connective
tissue disorders aOR 3.01; CI, 2.23-4.06, and
epilepsy and mood disorders aOR 1.41; CI, 1.161.7)
Unadjusted prevalence ratios maternal age > 35
yrs: TA 2.03, 95%, CI 0.80-5.14, dTGA- 2.37, CI
0.82-1.56, TOF-1.45, CI 1.10-1.91.
Mother 35 ≥ years of age: laterality CHD
aPR=2.03, 95%, CI, 1.01-4.10, conotruncal CHD
aPR=1.30, CI, 1.03-2.03, VSDs aPR=1.20, CI,
1.06-1.336, ASDs aPR=1.36, CI, 1.05-1.77,
DTGA aPR=1.65, CI, 1.10-2.48, COA aPR=1.54,
CI1.10-2.16.
Preterm infants (< 37 weeks) with CHD of black
mothers 4.2/10,000 compare to white mothers
6.8/10,000, Rate ratio (RR= 0.7**). Term infants
with CHD of black mothers 1.5/10,000 compared
to white mothers 1.3/10,000 (RR= 1.2*).
NHW 14.4/1000 live births, NHB 12.8/1000
(Rate ratio=RR 0.89 (95%, CI, 0.80-0.99), then
others 12.5/1000 (RR 0.58, CI, 050-0.69), NHB
8.8/100 (RR 0.61, CI, 0.54-0.68).
White mothers (n=3,259) aPR=42.4(CI, 41-43.9)
Non-white mother (n=2,016) aPR=38.1(RR 38.1,
CI, 36.5-39.8)

Note: TA, truncus arteriosus, dTGA, d-transposition of the great arteries, TOF, Tetralogy of Fallot, NHW, non-Hispanic White, NHB, non-Hispanic Black
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Table 1 (Continued)
Maternal
context

Article

Description

Race

Nembhard et al. 2010

Retrospective cohort using data from the Florida Birth Defects Registry-19982003. n=9,352/1,216,142. Prevalence for specific and all CHD among nonHispanic (NH)-white, NH-black and Hispanic infants was similar.

Chronic
health
conditions

Lisowski, et al. 2010

Multicenter retrospective clinical study, literature review and meta analysis
comparing the study population and in the literature of the offspring of type 1
DM mothers. Study showed an increased likelihood of specific heart anomalies,
transposition of the great arteries (TGA), persistent truncus arteriosus (PTA),
visceral heterotaxia and single ventricle (SV), among offspring of diabetic
mothers particularly in the first trimester. This study was in accordance with the
distribution in the literature.
Population based cohort study (n=2,278,838 maternal infant pairs, 26,488
infants with CHD) in Canada from 2002-2010. Several chronic maternal
medical conditions, including: diabetes, hypertension, connective tissue
disorders, and congenital heart disease, showed an increased risk of CHD in the
offspring.

TGA OR 2.85, 95%, CI, 1.92-4.23. PTA OR 4.72,
CI 2.21-10.08, SV OR 18.24, CI, 7.13-46.63.
Visceral heterotaxia OR 6.22, CI, 2.17-17.86.

Meta-analysis of influenza and congenital anomalies. Including neural tube
defects, hydrocephaly, CHD, cleft lip, digestive system and limb reduction
defects. First trimester maternal influenza exposure was associated with
increased risk of CHD.
Case- control study using data from BWIS, cases n= 2,361 controls 3,435.
Greater risk for CHD infants when mother had history of fever pre-and during
1st 3 months of pregnancy.
Prospective case- control study in Brazil- 302/303 controls. Risk factors for
CHD included, maternal antibiotic use, ETOH use, anti-hypertensive med use in
the 1st trimester

aOR 1.56; 95%, CI, 1.13-2.14, aortic valve
disorder aOR 2.59, CI, 1.21-5.54, VSD aOR 1.59
CI, 1.24-2.14.

Liu et al. 2013

Luteijn et al. 2010

Oster et al. 2011

Zen et al. 2011

Findings: Prevalence, adjusted prevalence ratio
Odds ratio, risk ratio(values are significant, p
<0.05*, p < 0.001**)
CHD prevalence per 10,000 live births- Hispanic80.09/10,000; NH-white 79.11/10,000; NH-black
77.67/10,000.

Risk factors: Maternal age ≥ 40 yrs, aOR, 1.48;
95% CI, 1.39-1.58), multi-fetal pregnancy aOR,
4.53; CI, 4.28-4.80, diabetes mellitus type 1: aOR,
4.65; CI, 4.13-5.24; type 2: aOR, 4.12; CI, 3.694.60, hypertension aOR, 1.81; CI, 1.612.03,thyroid disorders aOR, 1.45;CI, 1.26-1.67,
congenital heart disease aOR, 9.92; CI, 8.36-11.8,
systemic connective tissue disorders aOR, 3.01;
CI, 2.23-4.06, and epilepsy and mood disorders
aOR, 1.41; CI, 1.16-1.72.

Infants born with CHD -Fever: OR, 2.04: 95% CI,
1.27-3.27; influenza: OR 1.75; CI, 1.16-2.62.
Use in 1st trimester of anti-hypertensive OR 2.62;
95% CI, 1.00–6.87, Antibiotic OR 3.17, CI 1.556.49.
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Table 1 (Continued)
Maternal
Article
context
Family history
of CHD

Description

Findings: Prevalence, adjusted prevalence ratio
Odds ratio, risk ratio(values are significant, p
<0.05*, p < 0.001**)
Risk for CHD in offspring with 1 or more FH of
CHD, 1 CHD- 4.06%, 2 CHD- 2.9%, multiple
CHD 5% recurrence rates.

Fesslova et al. 2011

Prospective study with 1634 pregnant women with FH of CHD 1,477 cases with
single FH, 157 with multiple FH. 157 women were rescanned for multiple
pregnancies. Increased recurrence risk for CHD 3.98% when positive FH of
CHD.

Fung et al. 2013.

Prospective case control study in Canada 2008-20111 (n=2339 cases/199
controls). Family history, frequency of extra-cardiac anomalies (ECAs), and
antenatal risk factors were assessed using questionnaires and genetic testing.

Family history of CHD and frequency of major
extra cardiac anomalies was higher in cases versus
controls. Left heart lesions OR 2.8, 95%, CI 1.55.1, PDA OR 2.3, CI, 1.1-4.5, right heart lesions
OR 2.1, CI, 1.1-3.9, septal defects OR 2.1, CI, 1.13.9. Only 9.5% of cases with CHD had a
confirmed genetic diagnosis. Later year of birth,
family history of CHD, presence of major ECAs,
maternal smoking during pregnancy, and maternal
medication exposure were associated with
increased odds of CHD.

Øyen et al. 2009

National cohort study, Danish residents, 1,763,591/18,708 1977-2005. Specific
CHD showed variable but strong familiar clustering in 1 st degree relative
ranging from 3-80 fold increased prevalence of CHD compared to the general
population.

Among first-degree relatives, recurrence risk ratrio
79.1 (95% CI; 32.9- 190), heterotaxia, 11.7 ( CI,
8.0 - 17.0), conotruncal defects, 24.3 (CI,12.2 48.7), atrioventricular septal defect, 12.9 (CI,
7.48- 22.2) for left ventricular outflow tract
obstruction, 48.6 (CI, 27.5- 85.6) for right
ventricular outflow tract obstruction, 7.1 (CI, 4.5 11.1) for isolated atrial septal defect, and 3.4 ( CI,
2.2- 5.3) for isolated ventricular septal defect. The
overall recurrence risk ratio for the same defect
was 8.15 (CI, 6.95- 9.55), 2.68 (CI, 2.43 -2.97) for
different heart defects

Swaby et al. 2011

Convenience sample of 104 probands with 22q11.2 deletion syndrome were
compared to the general population prevalence of CHD in their 1 st-3rd degree
relatives. 4-5 fold increased risk for varying forms of CHD in these family
members.

15 (0.9%) of 1,663 relatives had CHD, increase
prevalence compare to general population, (OR
4.43, 95%, 1.03-40). Relatives with severe CHD
had significantly higher prevalence compared to
the general population (OR 5.88, CI 2.16-12.85).
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Table 2
Physical Maternal Contexts
Maternal
Article
context
Obesity

Alcohol

Description

Findings: Prevalence, adjusted prevalence ratio
Odds ratio, risk ratio (values are significant, p
<0.05*, p < 0.001**)
All CHD: In obese (BMI >30) women aOR
1.43(95%, CI, 1.05-1.95), conotruncal CHD, aOR
1.88(CI, 1.09-3.24).

Arias & Brown, 2010.

Case-control study in Rhode Island 2007-2009, N=995 cases, N=2344 controls.
Pre-pregnancy obesity was associated with increased risk of giving birth to an
infant with CHD, specifically conotruncal abnormalities.

Baardman et al. 2012

Case-control study in the Northern Netherlands, n= 658 cases/322 controls.
Smoking or high BMI alone, the risk for CHA in the offspring of women with high
BMI (≥25 kg/m(2) who also smoked was significantly increased.

Adjusted OR 2.65 (95% CI, 1.20 to 5.87) for all
CHD.

Mills et al. 2010

Population based nested case-control study. N= 7392 cases, 56,304 control. Obese
but not overweight women had increased risk of bearing children with CHD.

Obese= BMI ≥ 30, OR 1.15 (95%, CI 1.07-1.23).
Morbidly obese ≥ 40 OR 1.33 (CI 1.15-1.54).

Hobbs et al. 2010

Population case-control study 575/363 cases of mothers in Arkansas 1998-2007.
Maternal obesity, smoking and ETOH use can increase risk of CHD if mother has
functional SNPs in genes that encode folate-dependent pathways.

Obesity (carriers of 2 copies MTHFR 677 TT)
4.62 time (95% CI, 1.54, 13.83) > risk for CHD,
Smoked (G allele in TCII polymorphism) 1.81(CI,
1.06, 3.11) > risk for CHD, ETOH (GC or GG
genotype in TCII polymorphism) OR 1.71 (CI,
1.00- 2.92).

Stothard et al. 2011

Meta-analysis (18 articles). Obesity was found to be a small risk factor for
structural anomalies including CHDs.

BMI > 30 = obese, OR 1.30 (95%, CI, 1.12-1.51)
BMI 25-29 overweight OR 1.17 (CI 1.03-1.34).

Waller et al. 2007

Ongoing multisite case control study in the US, 1997-2002. Overweight= BMI 2530 171cases/858 controls. Obese ≥ 30 137 cases/572. Modest risk for all CHDs in
overweight and obese women.
Population based case control study of California births 1999-2003. Maternal
intake of ETOH less 1 day per week was associated with dTGA.

Overweight aOR 1.8 (CI 1.43-2.26). Obese aOR
1.5 (CI, 1.22-1.85)

Case control study extracted from the Pregnancy Risk Assessment Monitory
Survey (PRAMS) linked to birth certificate data from 9 states over 10 years (19962005). Significant increase in CHDs among mothers who reported binge drinking
> 1x in the 3 months prior to pregnancy.
Significant interaction between any binge drinking or binge drinking > 1x and
cigarette use.

Binge drinking > 1x in the 3 months before
pregnancy aOR 2.99, (95% CI, 1.19-7.51).
Any binge drinking or more once 3 month prior
pregnancy and smoking aOR 12.65 (CI, 3.5445.25) and aOR 9.45, (CI, 2.53-35.31).

Grewal et al. 2008
Mateja et al. 2012

DTGA: 76 cases, 425 controls OR 1.9(95%, CI
1.1-3.2).
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Table 2 (Continued)
Maternal
context
Alcohol

Article

Strandberg-Larsen
et al. 2010

Zen et al. 2011

Illicit drugs

Williams et al. 2004

Smoking

Alverson et al. 2011

Description

Cohort study using the data in the Danish National Birth Cohort 1996-2002. 477
infants with CHD, N=80,346 infant/mother pairs. No statistically significant risk
was found for CHD (ASD/VSD) in the infants in women who consumed lowmoderate (0-3 drinks/week) ETOH and infrequent binge drinking did not have a
significant risk for isolated CHD (ASD or VSD).
Case- control study in Brazil- 302/303 controls. Risk factors for CHD included,
maternal illness-fever, UTI, ETOH use, antihypertensive med use,
Atlanta Birth Defects Case control study found a 2 fold increase risk of VSD
with maternal self-reported marijuana use.
BWIS case controlled large study. Statistically significant associations for CHD
and maternal smoking in the 1st trimester. n=2525 case, 3435 control infants.

Findings: Prevalence, adjusted prevalence ratio
Odds ratio, risk ratio (values are significant, p
<0.05*, p < 0.001**)
VSD, 1/2-1 drink/wk, aPR=1.22(95%, CI, 0.901.66), 2 drink/wk, aPR=1.38 (CI, 0.83-2.28), 3+
drinks/wk, aPR=1.10 (CI, 0.54-2.23). Test trend
was 0.29.
UTI- p<0.001, Infection- p<0.001,
Antihypertensive med use- p=0.011, antibiotic use
p<0.001, ETOH use in 1st trimester p=0.066
RR for CHD; Marijuana- VSD 1.9; Ebsteins 2.4.
ASDs OR 1.36 (95%, CI, 1.04-1.78), RVOT OR
1.32 (CI, 1.06-1.65), PVS OR 1.5 ( CI, 1.05-1.74),
TA OR 1.90 (CI, 1.04-3.45), LTGA OR 1.79 (CI,
1.04-3.10)

Hobbs et al. 2010

Population case-control study 575/363 cases of mothers in Arkansas 1998-2007.
Maternal obesity, smoking and ETOH use can increase risk of CHD if mother
has functional SNPs in genes that encode folate-dependent pathways.

Obesity (carriers of 2 copies MTHFR 677 TT)
4.62 time (95% CI, 1.54, 13.83) > risk for CHD,
Smoked (G allele in TCII polymorphism) 1.81(CI,
1.06, 3.11) > risk for CHD, ETOH GC or GG
genotype in TCII polymorphism 1.71 (CI, 1.00,
2.92).

Lee & Lupo, 2013

Systematic review and meta analysis. The authors observed a positive
association between maternal smoking during pregnancy and the risk of CHDs
as a group. Women who smoked during pregnancy were more likely to have a
child with 12 (71 %) of 17 CHD subtypes analyzed compared with women who
did not smoke. Highest risk was for septal defects,

Smokers (RR, 1.11; 95 %, CI, 1.02-1.21. n =
18,282). Smokers and risk for septal defects RR,
1.44 (CI, 1.16-1.79). n = 2977.

Malik et al.2008

Population based case control n= 3,067 non syndromic CHD. Found an
association with right sided obstructive CHD and maternal smoking.

OR 2.1 (95%, CI, 1.2-3.5)

Patel et al. 2012

Multi site large population study 1997-2005, US. Case control study, n=187
cases/6703 controls. he association was strongest in mothers who smoked >25
cigarettes/day. Mothers with periconceptional passive smoke exposure were
more likely to have infants with AVSDs than unexposed mothers,
independent of maternal age, active periconceptional smoking, infant gestational
age, and family history of CHDs

Smoker (aOR 1.5, 95% CI, 1.1-2.4), Passive
smoke exposure (aOR 1.4, CI, 1.0-2.0).
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Table 2 (Continued)
Maternal
Article
context
Medication,
vitamin use

Findings: Prevalence, adjusted prevalence ratio
Odds ratio, risk ratio(values are significant, p
<0.05*, p < 0.001**)
Low-moderate maternal education level OR=3.43;
95% CI, 1.54-7.64 OR=1.56; CI, 1.00-2.45.
Housewives, workers higher risk OR=2.34; CI,
1.34-4.10 and office workers OR=1.28; CI, 0.792.07. Maternal smoking OR=1.48; CI, 0.82-2.67.

Kučienė & Dulskienė,
2009

Epidemiologic case control study in Kaunas 1999-2005, 187cases/643 controls.
Low and moderate maternal education significantly increased the risk of CHDs.
Housewives and workers had a higher risk of delivering a newborn with CHDs
than the office workers. Maternal smoking during pregnancy tended to increase
the risk of CHDs by 48%.

Alwan et al. 2010

Retrospective case control study of birth defects and risk factors. n= 6853
infants with CHD, n= 5869 controls born in 1997-2004 in the US. Positive
association between early pregnancy bupropion use and left outflow tract heart
defects.
Large regional registry (EUROCAT-Northern Netherlands), 1996-2005, casecontrol study. n=611cases/2401 controls. Mothers who used periconceptual folic
acid had an 18% reduced risk of delivering an infant with any CHD; a 38%
reduced risk for VSD.

aOR, 2.6; 95% CI 1.2-5.7.

Smedts et al. 2009

Case control study. Food frequency questionnaires were administered. 276
cases/324 controls in the Netherlands. Dietary vitamin E intake was higher in
case mothers than in controls. CHD risk increased with rising dietary vitamin E
intake. Periconception use of vitamin E supplements plus a high dietary vitamin
E intake above 14.9 mg/day had a up to nine-fold increased CHD risk. Retinol
intakes were not significantly different between the groups and not associated
with CHD risk.

Dietary vitamin E intake, OR 13.3 (CI 95%, 8.120.4) and OR 12.6 (8.5-19.8) mg/day.
Supplemental vitamin E intakes, Odds ratios at the
highest quartiles of vitamin E intake were OR 9.1,
(CI 2.0-41.4) and OR 4.8, (CI 1.1-20.2).

Zen et al. 2011

Case- control study in Brazil- 302/303 controls. Risk factors for CHD included,
maternal illness-fever, UTI, ETOH use, antihypertensive med use,

UTI- p<0.001, Infection- p<0.001,
Antihypertensive med use- p=0.011, antibiotic use
p<0.001, ETOH use in 1st trimester p=0.066

Grazuleviciene et al.
2013

Prospective cohort study 2007-2009 in Kaunas Lithuania. Cases n=57 CHD,
musculoskeletal n=37, urogenital n= 23. 3,074 women participated in
questionnaire. A dose response relationship for BDCM, DCBM both THMs in
the 1st month of pregnancy was noted for CHD

OR increased by 70% (OR 1.70, 95% 1.06-2.66)
for every 0.1 μg/d increase in the internal dose of
BDCM and by 26% (OR 1.26, CI 1.01-1.54) for
every 0.01 μg/d increase in the internal dose of
DBCM.

Van Beynum et al.
2010

Water

Description

Any CHD and folic acid supplementation
OR=0.82 (95%, CI, 0.68-0.997, septal defects, OR
0.62 (CI, 0.47-0.82)

Note: THM, trihalomethane, BDCM, bromodichloromethane, DBCM, dibromochloromethane.
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Table 3
Social Maternal Contexts
Maternal
Article
context

Description

Findings: Prevalence, adjusted prevalence ratio
Odds ratio, risk ratio(values are significant
<0.05*, p < 0.001**)
Older mothers & TCE exposure had 6 fold greater
CHD in case infants and control infants 3.3%,
95%, CI 8-245 vs. 0.5% 19-3780. Non exposed
older mothers OR 3.2, CI 1.2-8.7.

Water

Yauck et al. 2004

Case control study, Milwaukee, WI. n= 4025 infants. Older mothers ≥ 38 yrs
and had TCE exposure had greater risk of CHD in their infants than that of the
control group.

SES

Carmichael et al. 2009

Case-control study-California population n= 277 conotruncal defects, 608
orofacial cleft cases/ 617 controls. No increased risk for conotruncal defects in
lower/poor SES or educational levels.

Maternal education high school to college OR 1.01.9 (95%, CI 0.6-3.4), paternal education 1.0-1.6
(CI 0.6-2.8).

Kučienė & Dulskienė,
2009

Epidemiologic case control study in Kaunas 1999-2005, 187cases/643 controls.
Low and moderate maternal education significantly increased the risk of CHDs.
Housewives and workers had a higher risk of delivering a newborn with CHDs
than the office workers. Maternal smoking during pregnancy tended to increase
the risk of CHDs by 48%.

Low-moderate maternal education level OR=3.43;
95% CI, 1.54-7.64 OR=1.56; (CI, 1.00-2.45).
Housewives, workers higher risk OR=2.34; (CI,
1.34-4.10) and office workers OR=1.28; (CI, 0.792.07). Maternal smoking OR=1.48; (CI, 0.822.67).

Malik et al. 2007

Large population based birth defect registry (8 US states), case control study,
n=3,395 cases, n=3,924 controls. No statistically significant association between
maternal educational level or SES and SGA in the case or control groups. SGA
and CHD were significant.

SGA 516(15.2%), adjusted OR for state of
residence 2.07(95% CI, 1.78-2.40), adjusted for
infant race parity, maternal age at conception,
education, pre-pregnancy BMI, weight gain during
pregnancy, cocaine use 3 mo before pregnancy to
end, smoking and ETOH status 1 mo before
pregnancy to end, maternal HTN, and state of
residence. OR 2.09 (CI 1.78-2.46).

Cresci et al. 2013

Case control study in Italy, n=190 cases/190controls, maternal questionnaires
collected on preconception exposures and lifestyle practices. Higher frequency
of mothers of children with CHD (38 %) reported a positive history of exposure
to toxicants (occupational and environmental) than mothers of healthy children
(23 %) (p = 0.0013).

OR 2.6; (95 % CI, 1.6-4.2).

Occupation
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Table 3 (Continued)
Maternal
Article
context
Occupation

Occupation

Educational
level

Description

Findings: Prevalence, adjusted prevalence ratio
Odds ratio, risk ratio(values are significant, p
<0.05*, p < 0.001**)
Solvents, chlorinated solvents, VSD (OR 1.6,
95%, CI 1.0 to 2.6 and OR 1.7, CI, 1.0 to 2.8; any
solvent exposure with aortic stenosis (OR 2.1, CI,
1.1 to 4.1); and Stoddard solvent exposure with DTGA (OR 2.0, CI ,1.0 to 4.2), RVOTO defects
(OR 1.9, CI, 1.1 to 3.3) and PV stenosis (OR 2.1,
CI, 1.1 to 3.8).

Gilboa et al. 2012

Multi site population study in the US. Case control study. 2951 controls, 2047
cases. Associations were observed for exposure to any solvent and any
chlorinated solvent with perimembranous ventricular septal defects, aortic
stenosis, D-TGA, RVOTO defects and pulmonary valve stenosis.

Lin et al. 2012

Multi center case-control study of National Birth Defects Prevention Study dataUnited States (10 states), 1997-2004. n=4132 case/controls. Higher risk for
LVOTO defects in Nurses, septal defects in janitors and higher risk for
scientists-chemical, and engineers had higher risk for conotruncal defects.

Nurses- LVOTO defects OR 1.35, 95%, CI, 1.031.77, Janitor -septal defects OR 2.19, CI, 1.104.36. Chemical scientist - conotruncal defect, OR
2.44, CI, 1.01-5.91, engineer- conotruncal defects
OR 3.48, CI, 1.45-8.37.

Snijder et al. 2012

Age matched European case-control study 2003-2010 of cases 424 mothers, 421
fathers, controls 480 mothers, 477 fathers. No maternal exposure to specific
chemicals and increased risk of CHD was found. Increased risk for CHD and
exposure to specific chemicals in the father was found.

Mother OR 0.92, 95%, CI, 0.26-3.25. Fathers: OR
1.23, CI, 0.39-3.91.

Vaktskjold et al. 2011

Prospective cohort study, Russia, 1973-2005, included were mothers employed
as painters, painter-plasterers, and spoolers (all have exposures to solvents),
higher risk for circulatory system malformations in these groups.

Circulatory system (primarily aortic and mitral
valve disorders) OR 2.03 (95%, 0.85-4.84)

Carmichael et al. 2009

Case-control study-California population n= 277 conotruncal defects, 608
orofacial cleft cases/ 617 controls. No increased risk for conotruncal defects in
lower/poor SES or educational levels.

Maternal education high school to college OR
1.0-1.9, 95%, CI, 0.6-3.4, paternal education 1.01.6, CI, 0.6-2.8.

Kuciene & Dulskiene,
2009

Epidemiologic case control study in Kaunas 1999-2005, 187cases/643 controls.
Low and moderate maternal education significantly increased the risk of CHDs.
Housewives and workers had a higher risk of delivering a newborn with CHDs
than the office workers. Maternal smoking during pregnancy tended to increase
the risk of CHDs by 48%.

Low-moderate maternal education level OR=3.43,
95%, CI, 1.54-7.64, OR=1.56; CI, 1.00-2.45.
Housewives, workers higher risk OR=2.34; CI,
1.34-4.10 and office workers OR=1.28; CI, 0.792.07. Maternal smoking OR=1.48; CI, 0.82-2.67.
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Table 3 (Continued)
Maternal
Article
context
Educational
level

Malik et al. 2007

Description

Large population based birth defect registry (8 US states), case control study,
n=3,395 cases, n=3,924 controls. Found no statistically significant association
between maternal educational level or SES and SGA in the case or control
groups. SGA and CHD were significant.

Findings: Prevalence, adjusted prevalence ratio
Odds ratio, risk ratio(values are significant, p
<0.05*, p < 0.001**)
Total case subjects 3,395, SGA 516(15.2%),
adjusted OR for state of residence 2.07(95%, CI,
1.78-2.40), adjusted for infant race parity,
maternal age at conception, education, prepregnancy BMI, weight gain during pregnancy,
cocaine use 3 mo before pregnancy to end,
smoking and ETOH status 1 mo before pregnancy
to end, maternal HTN, and state of residence. OR
2.09(CI, 1.78-2.46).
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CHAPTER 3
Chapter 3 Introduction
The purpose of this chapter is to provide a review of the literature related to the
known genetic risk factors associated with CHD. The focus of this chapter will be the
known maternal genetic risk factors for CHD development in the infant. This chapter is a
review of the literature in the format of an article to be submitted for journal submission.
The referencing style of this target journal will be applied in this manuscript.
Manuscript 2: Understanding Genetics and Pediatric Cardiac Health
Abstract
Purpose: Congenital heart defects (CHD) continue to be the most prevalent birth defect
that occurs worldwide in approximately 6-8 of every 1,000 live births. High rates of
morbidity and mortality in infants, children, and adults living with CHD place a growing
need for health care professionals (HCPs) to better understand potentially modifiable
genetic and environmental influences. This paper will present examples of research and
governmental initiatives that support genetics education and research and a review of
known genetic factors associated with CHD development.
Organizing Construct: A review the known genetic factors on risk for CHD formation
in infants will be provided to help health care professionals gain a greater understanding
of the genetic influences on pediatric cardiac health.
Conclusions: There are known genetic pathways and risk factors that contribute to
development of CHD. This paper is a primer for nurses and HCPs providing information
of the genetics and inheritance patterns of CHD to useful in daily clinical practice.
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Clinical Relevance: Nurses work in multiple communities where they are uniquely
positioned to educate and provide information about research and current models of care
with families affected by CHD. Nurses and HCPs who better understand genetic risk
factors associated with CHD development can more promptly refer and offer treatment
for these children and families thus providing individuals of childbearing age with the
necessary resources and information about risk factors.
Key Words: Congenital heart defects, genetics, epidemiology, etiology, cardiac
development.
Introduction
Congenital heart defects (CHD) are the most prevalent birth defect in the world
and occur in approximately 6-8 of every 1,000 live births (Hoffman & Kaplan, 2002). It
is important to identify etiological factors of CHD as CHD is one of the leading causes of
infant morbidity and mortality. Only 10-15% of the etiologies for CHD are understood or
known. In 2001 The National Heart, Lung, and Blood Institute (NHLBI) convened a task
force in Pediatric Cardiovascular Disease to identify research priorities, and scientific
opportunities to address the growing public health problem of CHD in children and adults
(NHLBI, 2002). This task force identified eight research priorities that varied from
supporting basic science studies of the heart and blood vessel formation to transitional
research to enhance clinical care.
In 2012 the American Heart Association (AHA) publically recognized the impact
of genetics in diagnosing and directing treatment of cardiovascular disease (Ashley et al,
2012). The AHA published a policy statement and recommendations that prompt
clinicians to better understand and incorporate genetic technology and modalities into the
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care of children and adults with cardiovascular disease or increased risk of CHD. This
report addresses the following and provides recommendations for use of genetic
information in healthcare:


Legal ability and ramifications of patenting personal genetic material



Patient protection against genetic discrimination, regulation and monitoring of
genetic testing materials to deliver reliable and valid testing



Expert consensus on clinical involvement in recommending and selecting
appropriate current and next generation genetic testing



Multidisciplinary and multi-institutional involvement in adaptation for the use of
pharmacogenetics in disease treatment and management



Use of common variant and risk prediction genetic testing of the general
population-feasibility and risk for discrimination,



Reimbursement and insurance coverage for genetic testing,



Private and public access to genetic testing and storage of genetic material-ability
to monitor and protect



Education of “Core Competencies in Genetics and Genomics” for all healthcare
professionals (HCP’s)

Technology to identify genetic markers specific to heart disease continues to evolve
and is an innovative part of research and clinical care. Thus, greater knowledge of
genetics is required of HCP’s who care for individuals with or with increased risk of
CHD. This article is a primer for nurses and HCP’s providing a review of known genetic
factors associated with increased risk of CHD for use in daily clinic practice. The
implications for nursing research and clinical care will be presented in the conclusion.
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The Basic Building Blocks of Life
During the last two decades, scientists’ ability to map the human genome has
evolved and the complex molecular processes sustaining daily life continues to be
critically studied. As a central concept of molecular biology, the Central Dogma of
Molecular Biology describes the one-way directional flow of genetic information;
deoxyribonucleic acid (DNA) produces ribonucleic acid (RNA) which then produces
proteins (Strachan & Read, 2011). Although there are many complex processes and
components to the creation of genetic material, scientists noted that these essential
processes are needed by all cellular organisms to sustain life. Over the last several years,
scientists have appreciated that these processes and DNA are not the only factors
responsible for expressing our genetic makeup, but include more complex interactions
between various environmental, prenatal, and chemical exposures throughout an
individuals’ life. During this rapid evolution of molecular genetics, a new area of study
called epigenetics has developed to promote knowledge generation about the influences
the environment has on our genetic makeup.
Epigenetics is a rapidly evolving field of study that focuses on the interactions
and factors that influence chemical changes that switch parts of the genome off and on.
Epigenetic is defined as “Heritable (from mother cell to daughter cell, or sometimes from
parent to child), but is not produced by a change in DNA sequence” (Strachan & Read,
2011, pg. 724). The epigenetic mechanisms that influence changes in gene expression in
cardiac development include histone modifications, RNA interferences, and DNA
methylation (Chang & Bruneau, 2012; Vallaster, Vallaster & Wu, 2012; Weerd, KoshibaTakeuchi, Kwon & Takeuchi, 2011). These mechanisms occur within the cells that either
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silence or activate specific genes thus causing a cascade of events, which eventually
change the expression of the genetic material (Kim, Ryan, Marshboom, & Archer, 2011).
Epigenetic changes appear to be influenced by environmental conditions that
include famine, chemicals, and diet to name a few in which these exposure induced
changes may be passed to children and grandchildren (Perera & Herbstman, 2011).
Exposures to environmental disasters, chemical spills, or other naturally occurring events
disrupting the current conditions or environment over time may provide an explanation
for the increase in specific phenotypes that contribute to obesity, cancer or increased birth
defects as examples (Hou, Zhang, Wang & Baccurelli, 2011). As the human race has
learned to manufacture and sustain resources of water, food, and healthcare, the human
genome has also learned to adapt to the ever changing environment turning genes off and
on, sometimes with adverse effects.
As HCPs acquire a greater understanding of the complexity of molecular genetics,
this information will be important when exploring genetic factors influencing embryonic
and fetal development of the heart in relation to formation of congenital heart defects
(CHD). Of all cases of CHD in live births, 5%-10% can be attributed to a chromosomal
abnormality, and 3%-5% are linked to single gene defects (Botto & Correa, 2003; Brent,
2004). Therefore the majority of CHDs are thought to be of a multifactorial etiology,
resulting from a combination of environmental and gene interactions. Normal cardiac
development is a complex process and is influenced by many transcription factors and
cardiac-specific genes. CHD can develop at various times in embryonic/fetal
development during which teratogenic or chemical exposures may create varying types of

67
CHD that include but are not limited to valve disorders, muscular dysfunction, septal
defects or circulatory disorders resulting in cyanosis.
The classification and description of cardiac defects has been difficult due to the
complexity and multiple forms they come in. Categorizing CHDs genetically is also
difficult as some CHDs are heterogeneous with varying degrees of pathology. A
description of the multifactorial nature of CHDs and phenotype variability within humans
is discussed in the descriptions of each disorder and its associated CHD.
Genetics of CHD
The heart is formed during embryonic development -frequently before the mother
is aware she is pregnant. The primitive heart tube begins to form as early as embryonic
day 15 (Srivastava, & Olson, 2000). Various transcription factors signal cardiac genes to
begin cellular development and specification, creating the beginning of the cardiospecific regions and chambers of the heart seen around embryonic day 21. Through
embryonic day 28, the heart tube segments, ventricular chambers differentiate, and early
valvar regions begin to form. By embryonic day 50 the fully formed heart is visible with
each chamber, valve and vessel designated to support further fetal development of the
other body systems. Cardiogenesis is a complex process. Figure 1 illustrates the structural
changes that occur within the specific regions of the developing heart in the first 7-8
weeks of gestation. Each color illustrates the specification and differentiation during the
stages that form the fully developed heart. For example the purple and orange colors
represent the ventricular formation and specification of the right and left ventricles.
Through the process of looping (Days 21-28) the primitive heart tube begins
differentiating the atria, ventricles, conduction systems, arterial and venous circulation
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systems, each with specific regions and genetic material signaling the next process. If
there are genetic mutations or miscommunications along these routes various CHD
formations may occur. (INSERT FIGURE 1).
Single Gene Mendelian Mutations
Single gene Mendelian mutations account for approximately 3-5% of CHD in live
human births (Botto & Correa, 2003; Brent, 2004). Single gene Mendelian mutations are
those mutations occurring at a single locus or the unique chromosomal location which
defines the position of the individual gene or DNA sequence (Strachan & Read, 2011).
There are a small number of children and adults affected by familial inherited CHD, thus
it remains important to identify these individuals to assure proper allocation of resources.
The patterns of inheritance are classified into five categories: autosomal dominant (AD),
autosomal recessive (AR), X-linked dominant, X-linked recessive and Y-linked. The
basic Mendelian patterns of inheritance (Figure 2) can be complicated by other factors,
including penetrance of a trait, later presentation of a disease, and variable expression.
Although the probability of inheritance of a specific disease linked mutation can be
calculated, many other factors affect gene expression and the risk for disease. Referral to
an expert in genetics is appropriate for pre- and interconception counseling for families
with increased risk.
Autosomal dominant inheritance patterns are those in which either parent can pass
the affected gene to the offspring. There is a 50% risk in every pregnancy if one parent
carriers the affected allele that the offspring will express the trait. Male and female
offspring have an equal risk of being affected. In autosomal recessive inheritance
patterns, if both parents are unaffected carriers, there is a 75% risk in each pregnancy that
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they will receive the abnormal gene but only a 25% risk that they will be homozygous for
the diseased allele. Where one parent is an unaffected carrier of the autosomal recessive
faulty gene, and the other parent is affected by the condition, there is a 50% risk in each
pregnancy that the child will inherit both copies of the faulty gene.
In X-linked disorders, males will be affected if they inherit a faulty gene since
they only have one X chromosome. The male with an X-linked disorder pass their Y
chromosome to their male offspring thus none of their sons will be affected. However, all
of their female offspring will inherit the faulty gene, and present the disease if the trait is
dominant. In X-linked recessive disorders, the female is often a carrier of the trait, and
each female carrier has a 50% risk in each pregnancy that the male offspring will be
affected with the trait, and a 50% risk of passing the faulty gene to a female offspring. In
X-linked dominant traits, all female offspring are affected, and will pass the defect to
each of their offspring. Y-linked disorders affect only males, the affected father will
produce male offspring affected by the disorder (Strachan & Read, 2011). (INSERT
FIGURE 2)
Although there are only a small number of children and adults affected with
inherited CHDs; the developmental, physical, and financial impact can be substantial to
the child and family. HCPs need to be aware of the patterns and risk of inheritance for
the CHD disorders when women and men of childbearing age receive pre- and
interconception counseling. HCPs may have the ability to provide pre- and
interconception counseling so that individuals are able to make decisions about planning
a pregnancy with information about potential risk of having a pregnancy with a mutation
or birth/cardiac defect. Once a woman becomes pregnant, she should have access to
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genetic testing for single gene disorders through amniocentesis or chorionic villus
sampling. If a CHD is diagnosed, an early diagnosis allows time to screen with fetal
echocardiography and considerations for delivery plan of an infant affected with a CHD.
Since individuals with a genetic defect have up to a 50% chance of passing the genetic
defect in each pregnancy, pre- and interconception genetic counseling and screening
should be available in order to plan care for each pregnancy and infants with CHDs (Lin
& Garver, 1988).
Some examples of single gene disorders associated with CHD include Alagille
syndrome (AD), Duchene muscular dystrophy (X-linked), Noonan’s syndrome (AD),
Holt-Oram syndrome (AD), Marfan’s syndrome (AD), Char syndrome (AD), Williams
syndrome (AD) and Ellis-van Crevald syndrome (AR) (Carey, 2002; Hinton, Yutzey, &
Benson, 2005; Lin & Ardinger, 2005). Individuals with these disorders exhibit other
physical features which may include CHDs. It is important that HCP pay attention to
dysmorphic appearances in parents, siblings or the newborn, so that families receive
prompt genetic referrals, analysis and/or consultation with a genetic specialist. Although,
these disorders are linked to a single genetic pattern of inheritance, the type of CHD can
vary in degree of severity, again reiterating the multifactorial nature of CHD and role
exposures that can lead to epigenetic changes during one’s lifetime.
Chromosomal Abnormalities
Chromosomal abnormalities occur in approximately 1 in 150 live births (ACOG,
2007; ACOG, 2001; Cary, 2003). In this group of children with chromosomal disorders,
5-10% will have a CHD. Thus children with chromosomal disorders require prompt
cardiovascular evaluation to decrease or manage risk of morbidity and mortality
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associated with CHD. Many infants with chromosomal disorders will exhibit other
physical features prompting early genetic analysis to diagnose or determine if a disorder
is present.
Chromosomes are thread-like molecular materials of DNA and proteins that
contain genes which determine individual traits such as hair color or height. Humans
normally have 46 chromosomes, 23 chromosomes from each parent. Chromosomal
abnormalities are a result of large-scale mutations within the sperm or ova that occur
before fertilization. These mutations can occur from deletions (absence of a segment of a
chromosome), replications (extra copy or segment of a chromosome), mosiacisms (two or
more populations of cells with different genetic or chromosomal constitutions), or
translocations (a whole chromosome or segment of a chromosome becomes attached to or
interchanged with another whole chromosome or segment) resulting in varying forms of
diseases and disorders dependent upon the chromosomal region affected (Genetics Home
Reference, 2013). Certain chromosomal abnormalities will result in early fetal demise or
miscarriage.
There are several chromosomal abnormalities associated with varying forms of
CHD. For example, Turner’s syndrome, William’s syndrome, Trisomy 21, and DiGeorge
syndrome (Carey, 2002; Huang, Liu & Lv, 2010) may have varying forms of CHD or
may not exhibit any CHD. Trisomy 21 is the most frequent chromosomal abnormality
that occurs in 1 in 660 live births (Carey, 2002). Of the infants born with Trisomy 21,
approximately 40% will be affected with a form of CHD, and are most commonly an
atrioventricular canal defect, ventricular septal defect, and/or atrial septal defect.
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DiGeorge syndrome, 22q11.2 deletion, is found commonly in patients with
conotruncal defects such as Tetralogy of Fallot, aortic arch anomalies, truncus
arteriousus, and malaligned ventricular septal defects (Clark, Yutzey, & Benson, 2006).
The region of chromosome affected is the DiGeorge critical region (DGCR), where 30
genes are deleted in this region. There can be varying degrees of CHD, cognitive
function and other syndromes such as velocardio-facial and conotrucal anomaly face
syndrome seen in the DGCR abnormality.
Multifactoral Inheritance
The human genome is complex and the genetic processes which make up human
development are dependent on multiple complex reactions. Cardiac development is just
as intricate and complex which has made it difficult to isolate the exact mechanism of
CHD development with the many varying forms of CHD. Therefore with the
multifactorial nature of CHD, a genetic mechanism cannot be the sole focus as an
etiology. However, understanding possible genetic pathways and vulnerable stages to
specific exposures may allow individuals to experience decreases in risk of CHD.
The genetic mechanisms of the majority of CHDs, as well as many other disease
processes is thought to be a polygenic process; where multiple loci or areas on the
chromosome cause various effects on the phenotype (Strachan & Read, 2011). The
genetic environmental theory postulates that specific genotypes will produce or react,
dependent upon either optimal or suboptimal conditions in the environment, thus
affecting the phenotype (Falconer, 1952). As researchers uncover the intricate
relationships between the molecules of DNA, RNA, and epigenetic processes (e.g. DNA
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methylation, histone modification and RNA interference) and their roles in abnormal
heart development, the genetic environmental theory can be supported.
As there are multiple interactions between genetic materials and environmental
factors in males and females of childbearing age, women during pregnancy, and during
the first few weeks of fetal development, they should be aware of the known risk factors
for CHD. Understanding the potential risk factors for development of CHD is a goal for
both bench and clinical researchers working together to gain insight into the formation
and early identification of CHDs (Kaltman, Schramm, & Pearson, 2010). A summary of
the most common CHDs with known genetic causes, the genes and chromosomes that are
affected, and the modes of inheritance are provided in Table 1. It is important that
scientists and HCPs develop greater understanding of the epigenetic pathways in order to
provide information about risk for the heritable patterns across generations for nonMendelian disease.
Research Implications
The NHLBI has designed the Bench to Bassinet research program to encourage
and accelerate the discovery and translation of basic research of CHD etiology into
clinical studies through large scale collaborations of four large research centers in the
United States (Kaltman, Schramm, & Pearson, 2010). The NHLBI’s first goal in their
strategic plan is, “To improve understanding of the molecular and physiological basis of
health and disease, and to use that understanding to develop improved approaches to
disease diagnosis, treatment and prevention” (as cited in Kaltman, Schramm, & Pearson,
2010, pg 1264). The Bench to Bassinet Program is comprised of two research consortia:
the Pediatric Cardiac Genomics Consortium (PCGC) and the Cardiovascular
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Development Consortium (CvDC), administered through a common Coordinating Center
(CC), and aligns with the Pediatric Heart Network, which has been funded by NHLBI
since 2001. These groups are working on studies to accelerate the translation of basic
research findings into clinical studies and trials, and to provide clinical input on pressing
needs for basic research.
Multidisciplinary research in pre- and interconception care, prenatal health and
prevention of potentially harmful exposures to women and men of childbearing age is
important for nurses in the context of health promotion through the lifespan. Nurses are
uniquely positioned in the community and health care settings with readily available
access to young women and men of childbearing age. Engaging in further research to
address barriers or deficits in access to preventative and pre- and interconception
healthcare practices may provide another avenue to decrease CHD in infants. Nurses can
also identify “hot spots” or locations of multiple cases of CHD or other genetic
syndromes when employed in public health agencies, as well as various in- and outpatient
settings. Nurses have a unique opportunity to collect data and vital statistics to promote
further research of the multifactorial factors that contribute to CHD in infants.
Clinical Implications
With over three million nurses in various clinical, educational and research
settings across the United States, and over 19.3 million nurses worldwide (World Health
Statistics, 2011) nurses have strong potential to influence patient centered care and
research. Understanding genetic influences, resources and genetic testing to better
understand a disease process are necessary to provide comprehensive and preventative
care to children and families affected by and at risk for CHD and other genetic disorders.
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This initiative on genetic education in nursing is being promoted as a priority by the
American Association of Colleges of Nursing and the Council on Cardiovascular Nursing
of the American Heart Association (Ashley et al, 2012). Providing genetic education for
the nursing profession is essential to support and offer appropriate counseling and care
for this a growing number of individuals with and at increased risk for CHD. As the
infant with CHD grows into adolescence and adulthood, transition of care and education
of healthy lifestyles and informed reproductive choices are crucial to improve the lives of
our patients and families affected by and at increased risk for CHD. Several clinical
exemplars are presented in Figure 3 providing practical application of the modes of
inheritance (INSERT FIGURE 3).
These exemplars in Figure 3 illustrate different modes of inheritance from figure
1 of specific genetic cardiac conditions that nurses and HCPs may encounter in practice.
All members of the healthcare team must remain aware and knowledgeable about
physical characteristics, clinical results, and family history which may help determine an
increased risk for a genetic disease. Although, all nurses and HCPs may not all have a
comprehensive knowledge of all genetic disorders, it is important for nurses and HCPs to
provide a thorough health history and exam which may save a life and potentially
decrease the risk of CHD through informed reproductive choices of future generations.
There are many other genetic syndromes with various modes of inheritance outside of
CHD, and HCP’s need to be aware of the patterns of inheritance as they provide pre- and
interconception counseling to family members of childbearing age. The nurses and
HCP’s caring for children and families with genetic disorders or increased risk of genetic
disorders are not be solely responsible for the genetic expertise in various disorders, but
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must have, an adequate understanding of genetic transmission and risk in order to
appropriately refer individuals with questions or an increased risk of genetic diseases to a
genetic specialist and their team.
Conclusion
Nurses and other HCPs have a responsibility to obtain current knowledge about
genetics through education, research and review of current clinical practices in order to
provide multiple resources for individuals and families with CHD and increased risk for
other genetic disorders to optimize health outcomes. As the science of genetics is quickly
evolving, members of all health disciplines including nursing must maintain currency in
the research, clinical care, and education in the field of genetics. While genetic testing
may provide specific information to tailor individual care, pre- and interconception
counseling are critical to include with individuals at increased risk of a genetic disorder.
An understanding of basic genetics, genomics and resources available to nurses and all
HCP’s are critical to care for and promote health of individuals and families affected by
or at increased risk of CHD.
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Figure 1. Cardiac development

From the following article: A genetic blueprint for cardiac development. Srivastava, D. & Olson, E. (2000). Bilaterally symmetrical
aortic arch arteries (III, IV and VI); aortic sac (AS); conotruncal (CT) and atrioventricular valve (AVV); A, atrium; Ao, aorta; DA,
ductus arteriosus; LA, left atrium; LCC, left common carotid; LSCA, left subclavian artery; LV, left ventricle; PA, pulmonary artery;
RA, right atrium; RCC, right common carotid; RSCA, right subclavian artery; RV, right ventricle; V, ventricle. Used with permission
from Macmillan Publishers Ltd: Nature, Srivastava, D. & Olson, E.N. A genetic blueprint for cardiac development. Nature, 407, 221226A doi:10.1038/35025190, 2000.
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Figure 2. Patterns of inheritance for disease linked to a single gene polymorphism or mutation.
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Note: Patterns of genetic inheritance discussed in the text. Characters in red indicate a chromosome with a
disease-associated allele.
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Figure 3. Clinical Exemplars.
A 32 year old women is expecting a child, her husband has a diagnosis of Marfan’s syndrome, an autosomal dominant
syndrome. She is concerned for her risk of having a child with Marfan’s. She also wonders if her sister-in-law who
does not have Marfans’s is at risk. How would you address these concerns?




She and her husband have a 50% chance of having an affected child in each pregnancy due to her husband’s
genetic history.
A child with Marfan’s may not exhibit cardiac problems initially at birth and thus requires lifelong follow-up
with a cardiologist to monitor for mitral valve prolapse and ascending aortic dilation.
You would also advise your patient that her sister-in-law needs to address her risk with her physician because
you know that a comprehensive evaluation is needed to rule out the syndrome. However, you also know that
because this is an autosomal dominant syndrome one biological parent has to have the condition to pass it on
to their child. If her sister-in-law does not have the genetic condition she cannot pass Marfan’s on to her
offspring.

An Amish couple is at the cardiologist to discuss care of their child with common atrium and Ellis-van Creveld
syndrome, an autosomal recessive condition. She is concerned her next pregnancy may be at risk for this syndrome.
What is her chance of another. child with Ellis-van Creveld syndrome?



She and her husband have a 25% of having a child with this condition, and a 50% chance of having child who
is a carrier in this pregnancy and in each subsequent pregnancy.
If they have a child with Ellis-van Creveld syndrome, this child will have physical attributes of dwarfism
(short stature, short limbs) and can be at risk for an atrial septal defect or common atrium.

An 18 year old girl with Turner’s syndrome, an X-linked syndrome, comes in for follow-up of her surgically repaired
coarctation of the aorta. Her mother is concerned as she is entering adulthood and thinking about having children, what
is her risk for passing Turner’s syndrome on to her children. What are her chances of having a daughter or son with
Turner’s syndrome?




She has a 50% chance of having a female child with Turner’s in each pregnancy.
If her child is genetic positive for Turner’s syndrome a full cardiac evaluation is necessary as some children
with Turner’s do not have a cardiac condition. Coarctation of the aorta and bicuspid aortic valve are most
common CHDs.
Hypertension is a common condition in Turner’s syndrome which can manifest later in life.

In each of these cases, if a child does not inherit the genetic condition from his or her parents, the child will have the
same risk for CHD due to the multifactoral causes. The risk for CHD in a child is 6-8/1,000 live births.
Because the risk of inheritance with each of these conditions is the same in each pregnancy, a family with a family
history of each of these conditions and two children could have 1, 2 or no children with the condition.
Note: Clinical exemplars of genetic inheritance patterns for CHD.
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Table 1
Genetic Causes of CHD in the Human (congenital and adult CHD)
Types of CHD or
Syndromes Associated with CHD
Familial CHD (ASD, AV-block, TOF, HCM, TV
abnormality)
D-TGA, DORV
D-TGA
Tetrology of Fallot (TOF)

Pattern of
Inheritance
MF

Associated Genes or
Chromosomes
NKX2.5

MF
MF
MF

ASVD
ASD/VSD, ASVD, PV dysplasia
Heterotaxy

MF
MF
MF

CFC1
PROSIT240
ZFPM2
NKX2.5
JAG1
FOG2
CRELD1
GATA4
ZIC3, CFC1
ACVR2B, LEFTY A
ELN

Supravalvar AS
T/PAPVR, TA, PS
ASD, AVSD, AVB, TOF
Syndromes Associated with CHD
Holt-Orem syndrome
Alagile syndrome, PS/PPS
Char syndrome, PDA
Noonan syndrome, PS, PV dysplasia, ASD, AVSD

MF
MF
MF

CHARGE syndrome
Ellis-van Creveld, (ASD, common atrium)
Marfan syndrome
Connective tissue disorders
Cardiofaciocutaneous syndromes

AD
AR
AD
MF

KRAS BRAF MEK1
MEK2

Costello syndromes
Turner’s syndrome
William’s syndrome

AD
X-linked
AD

Trisomy 21, 18, 13
DiGeorge

MF
MF

HRAS
SHOX
CLIP2, ELN,
GTF2IRD1,
GTF2I, IMK1
Additional
chromosome
DGCR, TBX1, 22q11.2

AD
AD
AD
AD

GATA

TBX5
JAG1
TFAP2B
PTPN2
KRAS
SOS1
CHD7
EVC, EVC2
FBN1,TFGBR2

Note. AD, Autosomal dominant; AR, Autosomal recessive, ASD, atrial septal defect; AVB, atrioventricular
block; AVSD, atrioventricular septal defect; Chrom-Chromosome; D-TGA, dextro-transposition of the
great arteries; DORV, double outlet right ventricle; HCM, hypertrophic cardiomyopathy; MF,
multifactorial; PDA, patent ductus arteriosus; PS, pulmonary stenosis; PPS, peripheral pulmonary stenosis;
T/PAPVR, total/partial anomalous venous return; TV, tricuspid valve. Adapted from “Molecular
mechanisms of congenital heart disease,” by Huang, Liu, Sun, Lv, Ming, and Fan, 2010, Cardiovascular
Pathology, 19, e185. Copyright 2010 by Elsevier Inc.
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CHAPTER 4
Chapter Introduction
The purpose of this chapter is to provide a presentation and discussion of the
results from this dissertation study. The focus of this chapter will be findings from the
study including the risk factors for complex CHD and factors related to gestational age
and birth weight in this population. This chapter presents the outcomes of the study in the
format of an article to be submitted for journal submission. The referencing style of this
target journal will be applied in this manuscript. Supplemental data will include
correlation tables for both the dissertation as well as the journal submission.
Manuscript 3: Maternal Health and Infants Born with Congenital Heart Disease: A
Secondary Analysis of the WPCR
Abstract
Objective: Examine the relationships of select maternal variables to the type of CHD,
birth weight and gestational age in infants born with CHD participating in the Wisconsin
Pediatric Cardiac Registry (WPCR).
Design: Descriptive secondary analysis.
Setting: Wisconsin Pediatric Cardiac Registry
Participants: 1,687 parent/child participants
Methods: Descriptive analysis, correlations, logistic and multiple regression.
Results: Maternal history of CHD, OR 2.382 (95 % CI 1.424-3.984) and history of
serious health conditions OR 1.537 (CI 1.085-2.178) were found to increase the risk for
complex CHD in their infants. Predictors of birth weight included; maternal history of
hypertension, serious health condition six months prior or during pregnancy, CHD,
obesity and income (R² = 0.049, p < 0.05). Predictors of gestational age included;
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maternal history of hypertension, flu, and serious health conditions six months prior or
during pregnancy, and type of housing (R² = 0.045, p < 0.05).
Conclusion: Maternal history of CHD and chronic health conditions were associated
with increased risk for complex CHD in this sample. Nurses can identify risk factors of
CHD prior to pregnancy and provide education to women and their partners when
planning a future pregnancy. The findings from this study reinforces that there are risk
factors for complex CHD. It also illustrates the multifaceted nature of CHD and need for
further investigation of maternal and paternal exposures to help identify other risk factors
for complex CHD.
Key words: Congenital heart defects, pregnancy, cardiac, maternal exposures.
Congenital heart defects (CHD) are the most common type of birth defect
occurring in approximately 6-8/1,000 live births in the United States and continue to be a
leading cause of illness and death in infants (Hoffman & Kaplan, 2002). Although,
healthcare has made great strides in recognition and diagnosis of CHD, CHD prevalence
appears to be increasing (Botto, Correa, & Erickson, 2001). In 2004, an estimated $1.4
billion was spent for hospitalizations of individuals with CHD in the United States, of
that $511 million was used to treat complex CHD (Russo & Elixhauser, 2007).
During pregnancy a woman has many exposures within her environment of which
she may or may not be aware that can influence cardiac formation in her fetus. She, in
fact, may not be aware she is pregnant as cardiac formation occurs within the first 50
days of pregnancy (Sartiani et al, 2010). There is an increasing awareness of the sensitive
timeframe prior to and early in pregnancy and the influences of maternal health.
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The Wisconsin Pediatric Cardiac Registry (WPCR) was created in 1999 to collect
subjective and genetic information on the parents and infants of children born in
Wisconsin with various forms of CHD (Hanson-Morris, Pelech, 2006). It is estimated
that 400-600 new cases of CHD are diagnosed each year in Wisconsin (Hanson-Morris &
Pelech, 2006) or 6-7/1,000 live births (Harris et al., 2011). By studying the demographic
and subjective information provided from these families it was hoped to identify risk
factors for having an infant with complex CHD.
Maternal health and exposures have also been associated other birth outcomes
including birth weight and gestational age. Low birth weight and early gestational age
have been associated with maternal risk factors such as chronic health conditions
(Palmer, Bonzini, Harris, Linaker, & Bonde, 2013), history of smoking (Ashford et. al,
2010; Rogers, 2009) , and socioeconomic status (Blumenshine, Egerter, Barclay, Cubbin,
& Braveman, 2010; Jansen et al., 2009; Messer et al., 2008). In this group of infants with
various forms of CHD, it is hypothesized that these maternal risk factors are also
associated with the infants’ birth weight and gestational age as well as type of CHD. It is
important for women to optimize their health prior to and during pregnancy to decrease
the risk for low birth weight and premature birth. These infants with complex CHD were
also believed to be at greater risk for low birth weight and prematurity due to the
complexity of CHD diagnosis (Williams et al., 2010; Malik, Cleves, Zhao, Hobbs, &
NBDS, 2007).
This study was developed to address the relationships between the maternal
contextual factors and exposures prior to and during pregnancy to their birth outcomes
using the data in the WPCR database. Understanding the relationships of maternal health
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and contextual factors may identify risk factors for having an infant with CHD in this
sample.
Conceptual Framework
A life course perspective on health was chosen as a theoretical model to guide this
study as this theory conceptualizes health as a reflection of an underlying developmental
trajectory. The goal of the life course perspective is to understand, explain, and improve
health and disease patterns across various populations (Halfon & Hochstein, 2002). The
life course model uses a multidimensional approach incorporating the biological,
psychological, behavioral, and social contexts to better explain health and disease
processes of the person or community, allowing for the development of interventions and
education practices to identify risk and protective factors (Fine & Kotelchuck, 2010).
This model acknowledges throughout the developmental trajectory, some contexts
are fixed, or hard wired, and others contexts are highly flexible or amenable to change.
The life course model fits well in the study of CHD as many of the contexts are both
fixed and plastic occurring along a developmental trajectory. The life course model
reflects the epigenetic nature of diseases, or the heritable process of disease development
(from mother cell to daughter cell, or sometimes from parent to child), which is not
produced by a change in DNA sequence (Strachan & Read, 2011, pg. 724) and how
today’s experiences and exposures determines tomorrow’s health. Those health
trajectories are particularly affected during critical or sensitive periods (timing) and the
broader environment - biologic, physical, and social contexts – significantly affects the
ability to be healthy (Kotelchuck, 2011). Included in the study model were the maternal
contextual and risk factors identified through a review of the current literature (Butler,
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Johnson, & Cavan, 2014) (see Figure 1). The purpose of this study was to explore the
relationships of select maternal variables to the type of CHD, birth weight and gestational
age in infants born with CHD participating in the WPCR from 2000-2010. The
hypotheses evaluated were:
Hypothesis 1: Multiple maternal risk factors of biologic (genetic causes
associated with CHD, age, race, chronic health conditions, family history of CHD),
physical (history of obesity, use of alcohol, drugs, cigarettes, medication/vitamin use, and
type of water consumed), and social variables (SES, occupation, education level)
influence the risk of complex CHD.
Hypothesis 2: Multiple maternal risk factors (biologic, physical, social) influence
the risk of low birth weight or prematurity in the infants born with CHDs.
Methods
Design
Although, the original data were not collected with a specific research question in
mind, the WPCR was designed to allow researchers and clinicians access to temporal,
environmental, familial, and genetic data to explore relationships of potential causative
factors of CHD, which is congruent with the specific aim and hypotheses of this study. A
secondary analysis of preexisting data was used in this study. Approval was obtained
from Children’s Hospital of Wisconsin (CHW) Internal review Board for an exempt
study. Consent to participate was provided in the original study conducted at CHW and
no patient contact was required. All data was de-identified, maintained and accessed on a
secure computer. This sample represented approximately 1/3 of the infants with CHD
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and their caregivers who were consented and participated in the WPCR (1,687/4,919)
during this timeframe (Harris et al., 2011).
Setting and participants
Data for this secondary analysis were obtained from the WPCR database. The
original study included children that were conceived and born in Wisconsin after January
1, 2000, and diagnosed with a structural heart defect. Participants were identified and
recruited from pediatric cardiac referrals in Wisconsin. The cardiac defect was confirmed
from echocardiography, catherization procedures or autopsy. Exclusions included;
isolated patent foreman ovale, patent ductus arteriosus, electrophysiological disturbances,
and acquired heart diseases. The sample was limited to children under the age of two
years in order to reduce caregiver’s difficulty with recall bias when answering the
questionnaire (Harris et al., 2011). The present study contained 1,687 completed
questionnaires from the WPCR of infant and maternal information that were used.
Measures
Maternal context variables. The maternal contexts were divided into three
categories (see Figure 1); biologic (genetic causes associated with CHD, age, race,
chronic health conditions (CHC), family history of CHD) physical (obesity, ETOH/drug
use, cigarette use, medication/vitamin use, type of water consumed), and social contexts
(socioeconomic status (SES), occupation, education level). In the WPCR questionnaire,
only questions specific to the maternal context variables were used to measure these
concepts delineated in the conceptual framework. Several concepts were represented by
multiple questions to better capture the maternal contexts in this sample (see table 1).
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Infant outcomes. Three infant outcomes were used in the model; simple or
complex CHD, gestational age and birth weight. The type of CHD variable was created
using a modified classifications schema modified from the Baltimore Washington infant
study (Ferencz, Loffredo, Correa-Villaseñor, & Wilson, 1997). All CHD diagnoses were
provided by ICD-9 codes which were recorded by the research coordinator. Simple CHD
was defined as a single CHD diagnosis of: atrial septal defect (ASD), ventricular septal
defect (VSD), pulmonary valve disorders (PV), coarctation of the aorta (COA), and
bicuspid aortic valve (BAV), mitral valve disorders (MV). Complex CHD was defined
as: multiple CHD diagnoses and/or the diagnoses of Tetralogy of Fallot (TOF),
atrioventricular septal defect (AVSD), transposition of the great arteries (TGA),
pulmonary atresia (PA), hypoplastic left heart syndrome (HLHS), univentricular heart
disease or variants including multiple lesions.
Statistical Analysis
An initial evaluation of the dataset was undertaken to determine which items
would be used to measure study concepts. After thorough evaluation of numeric, text data
and cleaning of the dataset, 29 variables were chosen to measure the 14 maternal context
variables proposed in this study. Variables were omitted if they included free text data,
had more than 30% missing data, or were slightly different in the print or online
questionnaires. A power analysis based on the work of Peduzzi et al. (1996) was
performed to determine adequacy of size of the sample. Using the formula of N=10k/p
(k=number of covariates) (p=the smalls of the proportion of negative or positive cases).
N=10(15)/.3, N= 500; 500 cases were required for this study. A total of 1,687 cases were
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available for study which was well over the 500 cases needed to identify significant
relationships between the independent and dependant variables.
Characteristics of the sample were identified through descriptive analysis.
Frequencies were used to describe the sample and to assess for skewness (distribution),
kurtosis (clustering), central tendencies, and variability of the variable. Means, medians
and standard deviations were calculated for continuous variables. Percentages were used
for dichotomous and categorical variables. Demographic (race-Caucasian, water typecity, marital status-married, income->$25,000 and education-some college) categorical
variables were collapsed into dummy variable (yes or no) for the regression analysis.
Pearson’s correlations, Spearman rho correlations, Phi coefficient and Cramer’s V tests
were used to examine relationships between predictor and outcome variables. Only the
significantly correlated variables were included in the final regression models
(Tabachanick & Fidell, 2013).
An assessment of the reduced dataset (text in variables eliminated) using Little’s
test determined patterns of the missing data. Little’s test was significant at .885, p <.001,
indicating the interval variables showed a pattern of data missing completely at random
(MCAR) (Tsikriktsis, 2005). One categorical variable had 12.2% of missing data which
remained below 15% missing and was retained. The remaining categorical variables had
< 5% missing data. Because the majority of missing data was less than 10%, multiple
imputations were used to impute the missing data (Tsikriktsis, 2005).
A direct logistic regression was performed to access the impact of a select number
of maternal context factors (predictors) on the likelihood of having a child with complex
CHD (outcome) in hypothesis 1. The logistic regression model was conducted with three
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significantly correlated biologic maternal contexts (age, serious health condition six
months prior or during pregnancy, and history of CHD) and two social maternal contexts
(income and educational level). Correlations were noted to be small but significant (see
tables 7-10).
Two hierarchical multiple regressions analyses were used to test hypothesis 2 and
determine predictors for gestational age and birth weight. Preliminary analyses were
conducted to ensure no violation of the assumptions of normality, linearity,
multicollinearity and homoscedasticity (Tabachanick & Fidell, 2013). An exploratory
correlational analysis was also undertaken to address the following question. Does type
of CHD (simple or complex) influence birth weight and/or gestational age? Pearson’s
correlations were used to address this exploratory research question.
Results
Sample Characteristics
This sample of 1,687 infants and mother dyads had overall normal birth weight
(mean 3.178 kg/7#, 11.2 oz) and gestational age (mean 37.92 weeks) in the infants in this
sample. The women in this sample were generally healthy with few chronic health
conditions and healthy age for child bearing (mean 29 years). In this sample sex was
equally distributed of 51% male and 49% female infants with CHD. Of these infants 73%
had simple CHD, and 27% had complex CHD (see table 2).
The majority of the mothers in this sample were Caucasian, married, and
educated with some college. These women were mildly overweight (mean BMI=26,
overweight= 25-29.9) and 17% reported history of obesity. Most were middle to upper
class living in single family homes. Many of these mothers were healthy with asthma
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noted most frequently as a chronic health condition (29%). The majority of these women
used multivitamins prior and/or during pregnancy (91%) and less than a 25% reported
taking a prescription medication. Many women reported history of smoking (41%) and
the majority consumed alcohol (70%). Few reported using illicit drugs (< 2.3%). Over
75% of the women worked prior their pregnancy and continued to work during their
pregnancy (See table 3, 4).
Predictors of complex CHD
To test the first hypothesis a direct logistic regression was performed entering the
variables by domain per the conceptual framework. The final model contained five
significantly correlated maternal context variables (see tables 7-10). The model as a
whole containing all predictors was statistically significant, χ² (5, N = 1687) =34.1,
p<.001, indicating that the model was able to distinguish between subjects with simple or
complex CHD. The model explained 2% (Cox & Snell R²) and 2.9% (Nagelkerke R²) of
the variance in type of CHD (simple/complex) and correctly classified 73.1% of complex
CHD cases (Field, 2013). As shown in Table 5, two context variables made a uniquely
statistically significant contribution to the final model, maternal history of serious health
condition and history of CHD. The strongest predictor of having an infant with complex
CHD was maternal history of CHD, (B=.420, SE = .179; Exp(B) =2.389), indicating that
mothers who had a history of CHD were 2.4 times more likely to have an infant with
complex CHD. These mothers with history of a serious health condition prior or during
the pregnancy was a significant predictor of complex CHD (B=.871, SE = .262; Exp(B)
= 1.523), were 1.5 times more likely to have an infant with complex CHD (see Table 5).
Predictors of Birth Weight and Gestational Age.
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To test the first part of hypothesis 2, which studied the predicators of birth weight,
nine significantly correlated maternal variables to birth weight were into the regression
using the domains in the conceptual framework (see tables 7-9). The significant
correlations were small (r = < 0.1).
A hierarchical multiple regression were performed to assess the ability of the nine
maternal context variables to predict birth weight of the infant born with CHD (see Table
6). Biological variables, age, maternal race, history of respiratory infection, hypertension,
serious health conditions and history six months prior or during pregnancy of CHD were
entered at Step 1, and explained 3.1 % of the variance of birth weight. The physical
variables history of obesity, BMI, and income level entered in Step 2, explained another
1.3 % of the variance and all of but history of respiratory infection, remained significant,
R² change = .013, F change (2, 1592) = 10.486, p <.001. In Step 3 the addition of social
variable of income level explained .6 % of the variance, R² change = .006, F change (1,
15911) = 10.125, p < 0.05. In the final model five maternal context variables were
statistically significant explaining a total of 4.9% of the variance in the final model.
History of hypertension, serious health conditions, obesity, annual income and history of
history of CHD remained to be significant predictors of birth weight in the final model
explaining 4.9% of the variance of birth weight.
To determine predictors of gestational age, six maternal variables with significant
correlations to gestational age were entered into the hierarchical regression using the
domains in the conceptual framework (see table 7-9). The significantly correlated
variables had small correlations (r = < 0.1).
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Biologic variables, history of emotional disorder, hypertension, flu and serious
health conditions six months prior or during pregnancy were entered at Step 1, and
explained 3.8% of the variance of gestational age. The physical variable of alcohol use
was entered in Step 2, which explained another .2 % of the variance. In Step 3 with the
addition of a social variable, type housing, .4% of the variance was explained, R² change
= .004, F change (1, 1680) = 7.875, p < 0.05. In the final model four maternal context
variables (history of HTN, flu, and serious HC, and type of housing) were statistically
significant explaining 4.5% of the variance of gestational age (see table 6).
Exploratory Analysis.
The type of CHD was not significantly correlated with birth weight and
gestational age (BW= -.014, GA .011, r). In this study type of CHD did not influence
gestational age and birth weight.
Discussion
Two significant relationships were obtained between the maternal context
variables (serious health condition and history of CHD) and risk for complex CHD.
Although the model had 14 maternal context variables, only five significantly correlated
variables were retained for the logistic regression. In this sample the majority of women
were generally healthy, educated and had minimal reported substance use that would be
put them at risk. However, history of a serious health condition showed a 1.5 fold
increased risk for complex CHD in their infants.
Having a serious health condition or chronic health condition prior to or during
pregnancy has been associated greater risk for all CHD (Miller et al., 1981; Oster, RiehleColarusso, Alverson, & Correa, 2011; Srinivasan, Dheen, & Tay, 2007). Although the
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type of illness or serious health condition is not well delineated to type of illness or exact
timing in this sample, it does support that there is a relationship with history of any
chronic illness and increased risk of CHD if present prior or during pregnancy.
In this study we found an associated greater risk for complex CHD when there
was maternal history of CHD, 2.4 fold increased risk. The BWIS (1997) reported an
increased risk for CHD when there was first degree family history of CHD (OR 4.1, CI
1.6-10.7), however they did not find an association with greater risk complex CHD.
Romano-Zelehka et al.’s (2001) study which found increased risk for CHD (aOR 1.73, CI
0.89-2.44), most commonly ASDs, when there was parental history of CHD. Although,
the exact mechanism of inheritance remains unknown it is consistent with the multi-genic
complex developmental process and greater propensity for producing offspring with
CHD when there is family history of CHD (Ferencz et al., 1989).
The second hypotheses revealed several maternal context predictors influencing
gestational age and birth weight of this sample. Although these maternal context
variables were statistically significant, they only explained about 4-5% of the variance in
the outcome variables (gestational age, birth weight). Gestational age and birth weight
did not statistically impact risk for complex CHD in this sample and maybe be related to
the socioeconomic status of this population. The findings of no relationship were not
consistent with other studies. Some have found the greater the severity of the CHD the
greater risk for prematurity and low birth weight are present (Malik, Cleves, Zhao, Hobbs
& NBDS, 2007, BWIS, 1997).
In the model 4.4% of the variance was explained. Although, 95% if the variance
was not explained by this model, this study identified specific risk factors for lower birth
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weights in these infants’ born with CHD from a relatively healthy group of women.
Maternal history of hypertension, serious health condition, CHD, obesity six months prior
or during pregnancy were consistent with the literature finding poor birth outcomes when
CHD was present (Stochard, Tennant, Bell & Rankin, 2011). Obesity in this study was
significant and also has been associated with a number of congenital malformations
including neural tube defects and CHD (Mills, Troendle, Conley, Carter & Druschel,
2010; Stothard, Tennant, Bell & Rankin, 2009; Watkins & Botto, 2001).
The common risk factors associated with CHD and other birth defects, such as
alcohol (Jenkins et al, 2007; Matok, Pupco, Koren, 2011), illicit drug use, smoking
(Alverson, Strickland, Gilboa & Correa, 2011; Gianicolo, Cresci, Ait-Ali, Foffa &
Andresassi, 2010; Sartiani et al, 2010) and teratogenic exposures did not significantly
correlate with type of CHD or poor birth outcomes. Although, these risk factors are
associated not only with CHD but other birth defects, if the mother does not report such
exposures, further review of health history for chronic health conditions and social
history should be reviewed as our sample had other identifiable risk factors.
There was a relationship of each of maternal contexts and one of the infant
outcomes. However, in the exploratory analysis in the conceptual that were not supported
by the findings of this study was the relationship between type of CHD and birth weight
or gestational age. Although gestational age and birth weight were highly correlated to
each other neither was correlated to type of CHD. If future research using a more diverse
and larger sample supports our findings, the conceptual framework may be revised.
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Statistical considerations and limitations
The large sample available in the dataset allowed for relationships to be explored
comparing birth outcomes of the infants born with CHD, however these risks cannot be
inferred to the infant without CHD. Alcohol, smoking and drug use questions were used
in this study but from review in the literature, the accuracy of information about sensitive
questions such as smoking, alcohol and drug consumption can be a problem in survey
data (Van de Mortel, 2008; Del Boca & Darkes, 2002). Poor recall or bias in reporting
these variables may account for the lack of relationships identified in this study.
Generalizability may be limited as the sample is included only infants born in the state of
Wisconsin from 2000-2010 which is a predominantly Caucasian, middle class,
Midwestern state. The finding may not be representative of other demographic locations
in the United States.
Most research exploring CHD risk factors and prevalence has used a control
group for comparison; however, an adequate control group was unavailable for this study
but not essential to test the hypotheses. The BWIS (1997) was the largest population
study to identify multiple risk factors for CHD. In the BWIS, although a case control
study, CHD type was classified according to severity and risk factors for the types of
CHD ranging from simple, moderate and complex. More risk for complex CHD was
identified when there was maternal history of chronic health conditions.
Specificity of critical time frames of exposure is limited in this study. This study
uses cross sectional data collected over a decade, thus predictors must be interpreted
cautiously as it does not indicate causal evidence. The maternal variables reporting
history of illness, chronic health conditions, serious health conditions and obesity all were
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measured using a six month prior to or during pregnancy timeframe. Some of the
variables were non-specific such as the serious health condition variable. These variables
which were available may have been a factor in the prediction of the model rather than a
flaw in the model itself.
In this sample serious health conditions were found to be a greater risk for
complex CHD. This finding may be influenced by the general health status of the
sample. Due to the lack of a sufficiently robust control sample and the type of serious
health condition cannot be determined, the most influence health condition affecting risk
for complex CHD cannot be elicited. Additional research will be needed to clarify these
relationships.
Implications for Practice and Research
In this study we found several significant maternal risk factors for having an
infant with complex CHD. These maternal context factors were also significant
predictors for birth weight and gestational age in this population. Although the sample
was limited, the findings can be used to guide the assessment of women’s health history
and health practices. This study supports the practice of a thorough review of health
history and health practices with all women to identify potential risk factors for having an
infant with CHD. In the recently published Scientific Statement for the management of
fetal cardiac disease (Donofrio et al. 2014), it is recommended that women with personal
history of CHD, specific CHC’s or infections (pre-gestational diabetes, lupus,
hypertension- on ACE inhibitors, rubella), or history of known genetic condition have a
fetal echo performed. These maternal conditions are just a few examples indicating the
necessity of a prenatal cardiac evaluation due to increased risk for CHD. There are
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several modalities for prenatal cardiac evaluation dependant on the maternal history and
type of congenital heart disease present during pregnancy. If CHD is diagnosed promptly
in the prenatal timeframes planning and/or management can be provided to ensure
optimal outcomes of the infant and pregnant woman can be initiated.
The use of electronic medical record systems has been a nationwide undertaking.
Many nurses are using an electronic medical record (EMR) system; accurate recording of
family history, past medical history and social history may facilitate screening of women
and families. A three generation genogram may be critical in the identification of cardiac
risk factors for future pregnancy (Wright & Leahey, 2013). Development or training for
use of an electronic version in the EMR may be helpful and resourceful for a busy
practice. Review of these families educational level, occupation, and medical history can
help identify at risk women and families when previewed by the health care professional.
Accessing programs and obtaining suitable teaching materials may assist at risk
individuals and provide opportunities to review current recommendations for healthy
pregnancies. Many of the maternal risk which we have identified in this study can be
identified through thorough history and physical assessment at routine health visits. The
known modifiable risk factors should be discussed with all women and their partners who
are contemplating pregnancy.
Inclusion of the man’s health and exposures is extremely important and often
overlooked. As we learn more about epigenetic influences and the influences of
generational health practices, a thorough health history for both woman and man will be
necessary to identify risk factors for birth defects, particularly CHD for example when
there are multiple family members reporting history of CHD. It is being better
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understood the exposure history of the father may have as great of an impact on the risk
for CHD development during the pre-pregnancy stage as well as at conception as the
woman. Nurses and HCP’s can help identify these risks factors and provide counseling to
these families and future generations for good healthcare practices prior to pregnancy to
help decrease the risk of complex CHD and promote healthy infant outcomes. As our
healthcare systems shift to a preventative model for healthcare delivery, nurses can excel
in leading prevention and education.
The conceptual framework was generally supported the by relationships between
the maternal contexts and infant outcomes. However, not all relationships between
maternal contexts and outcomes in the model were supported by the data; physical and
social contexts were not related to type of CHD. The biological realm showed the most
influence on type of CHD which could be due to the generally healthy sample. Or it may
be related to a biologic predisposition occurring early in cardiogenesis that does not
influence the type of CHD but rather the development of CHD in general. Interestingly
the relationship between type of CHD and birth weight and gestational age were not
supported as previously suggested in the literature (Williams et al., 2010; Malik, Cleves,
Zhao, Hobbs, & NBDS, 2007). Future research may better clarify these relationships
which then the conceptual framework could be modified accordingly.
Summary
CHD continues to be the leading birth defect occurring worldwide. There are
known risk factors which can be identified to help decrease the risk of complex CHD,
premature birth and low birth weight in infants. It is important to discuss the risk factors
with our families of childbearing age to raise awareness for positive health practices
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which may contribute to reducing the risk of complex CHD. Prenatal diagnosis of
complex CHD through fetal echo and other modalities can assist in providing optimal
outcomes of the infant and pregnant woman. Continued research in this area is needed
but also inclusion of the paternal health practices. It is necessary to capture the entire
family as one of the most significant risks for complex CHD is personal maternal history.
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Figure 2.
Call outs: (3 required- no more than 25 words each)
Call out 1: After introduction
Congenital heart defects are the leading birth defect in the world. Positive prenatal
maternal health practices can help decrease risk for complex CHD.
Call out 2: Before the results section
Maternal history of CHD increases risk for having a child with complex CHD.
Call out 3: Prior the discussion
Identification of at risk women prior to pregnancy is critical in reducing their risk of
complex CHD for future pregnancies.
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Table 1
Maternal questions used in analysis
Domain
Infant

Context
Gestation
Gestation
Birth weight
Race
Age
Genetic causes

Question
What was mother’s expected delivery date?
When was mother‘s last menstrual period prior to this pregnancy?
How much did your baby weight at birth? Lbs/oz.
Biologic
Please circle mother’s race or ethnic group.
What is mother’s date of birth?
Did/does mother have any birth defect, malformation, or condition other than CHD
which was present from birth?
FH CHD
Did/does mother have a CHD, heart condition that she was born with?
CHC
Has mother ever been told she has diabetes?
CHC
Has mother ever been told that she has any of the following illnesses?
(asthma/allergies, epilepsy, thyroid, peptic ulcer, eating disorder, cancer, other)
CHC
In the 6 months prior to or during this pregnancy did mother have any of the following
illnesses or conditions? (high blood pressure, obesity, bladder or kidney infections,
emotional, vaginal infections, arthritis, headaches, colds, sinus infection, bronchitis)
CHC
In the 6 months prior to or during pregnancy did mother have or was mother exposed
to anyone with the following infections? (influenza, mumps, measles, rubella, chicken
pox, hepatitis, AIDs/HIV)
CHC
In the 6 months prior to or during pregnancy did mother have any other serious health
problems or was she hospitalized for any reason, excluding delivery?
Physical
Med/vit
Did mother take vitamins or multi-vitamins during this pregnancy?
Med/vit
During this pregnancy did mother regularly take medications not mentioned above?
Obesity
Mothers height
Obesity
What was mother’s pre-pregnancy weight?
Tobacco
Did mother ever smoke cigarettes?
Alcohol
In the 6 months prior to or during pregnancy did mother drink any alcoholic
beverages?
Alcohol
On average, how often did mother drink alcoholic beverages during the 6 months prior
to or during pregnancy?
Drug
During this pregnancy, did mother use any of the following drugs? (cocaine,
marijuana, hash/hashish, amphetamines, pain killers, glue sniffing, crack, heroin,
barbiturates, valium, other)
Water
What was the source of mother’s drinking water during this pregnancy?
Social
SES
Select the category that best represents the total annual family income.
SES
What is mother’s marital status
SES
In what type of house did mother live?
Education
What was the highest grade of schooling mother has completed?
Occupation
Was mother working during the 6 months before she became pregnant?
Occupation
Was mother working during this pregnancy?
Note: CHC, chronic health condition, FH CHD, family history of congenital heart defect, SES, socioeconomic status.

Table 2
Infant Demographic Characteristics
Infant outcomes
Gestational age
Birth weight
simple
complex

Mean
37.92weeks
3.17 kg

Range
24-45weeks
.54-5.37 kg

N
1,687
1,687
1,232
453

%

73
26.9
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Table 3
Maternal Characteristics (n=1,687)
Maternal Context

Maternal Context
Variables

Demographics

Biologic

Age

Mean 29.19
SD 5.739
Range 14-48
4.2 % African American
1.4 % Asian
86.2 % Caucasian
4.4 % Hispanic
1.6 % Native American
2.2 % Other
Mean 26
SD 6.26
Range 15.19-56.57
62.8 % city
20.3 % well
13.6 % bottle
3.3 % other
17.7 % single, widowed
78.9 % married
3.3% divorced, separated
69 % single family
12.8 % row/duplex/townhouse
13.1 % apartment
3.4 % trailer
1.6 % other
7.5 % < $10
7.1 % $10-19999
7.2 % $20-24999
21.9 % $25-49999
40.4 % $50-99999
14.1 % >$100K
6.9 % grammar
27.7 % HS/equiv
11.6 % voc/tech
18.2 % some college
23.6 % bachelors
10.4 % masters
1.6 % doctorate

Race

Physical

BMI

Water type

Social

Marital

Housing

Income

Education
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Table 4
Maternal Health and Substance History (n=1,687)
Maternal Context

Maternal Context
Yes
Variables
Biologic
Chicken pox/exp
4.9%
Birth defect
5.9%
CHD
7.7%
Diabetes
7.8%
Bladder
11%
HTN
11.4%
Serious HC
13.8%
Emotional disorder
14.5%
Flu or exp
23.1%
HA
32.9%
Respiratory infection
46.9%
Physical
Painkillers
2.7%
Marijuana
2.9%
Hx obesity
16.6%
Pres drug
25.4%
Ever smoke
40.7%
Alcohol use
67.9%
Vitamin
91.3%
Social
Work during
76.5%
Work before
79.4%
Note: HA=headache, HTN=hypertension, SHC=Serious health condition, CHD=congenital heart defect

Table 5
Logistic regression for predictors of type of CHD (simple complex or complex)
Maternal
B
S.E.
Wald df
p
Context
Variables
Step 1 Biologic
Age
-.025
.010
7.211 1
.009
SHC
.436
.178
6.446 1
.014
CHD
.842
.262
9.742 1
.001
Step 2 Social
Age
-.012
.011
1.100 1
.297
SHC
.420
.179
5.916 1
.019
CHD
.871
.262
10.500 1
.001
Income
-.053
.049
1.008 1
.285
Education
-.069
.044
3.526 1
.118
Note: SHC=Serious health condition, CHD=Congenital heart defect
*p < .05, **p < .001

Odds Ratio

95% C.I.
for OR
Lower

Upper

.975
1.546
2.322

.957
1.091
1.389

.994
2.192
3.880

.989
1.523
2.389
.949
.934

.967
1.073
1.429
.862
.857

1.010
2.161
3.996
1.045
1.018
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Table 6
Hierarchical Regression coefficients for predictor variables
B
Birth weight
Step1 Biologic
Race
Age
Resp inf
HTN
Serious HC
CHD
Step2 Physical
Race
Age
Resp inf
HTN
Serious HC
CHD
BMI
Obesity
Step 3 Social

S.E.



.66437
.035
.003
-.075
.228
.200
-.158

R2

R2

.031**

.031**

.043**

.013**

.049*

.006*

.037
.025
-.048*
.105**
.100**
-.063*
.66045

.037
.002
-.064
.257
.213
-.164
.002
-.179

.040
.021
-.039
.118**
.107**
-.065*
.021
-.099*
.65857

Race
.034
0.36
Age
-.003
-.024
Resp inf
-.064
-.039
HTN
.249
.114**
Serious HC
.217
.109**
CHD
-.170
-.068*
BMI
.004
.040
Obesity
-.162
-.091*
Income
.044
.091*
Gestational age
2.244
.038**
.038**
Step 1 Biologic
Emotion
.277
.050
HTN
.628
.089**
Flu
-.308
-.061*
SHC
.955
.142**
2.242
.040
.002
Step 2 Physical
Emotion
.257
.047
HTN
.620
.088*
Flu
-.287
-.056*
SHC
.958
.142**
Alcohol
-.195
-.043
2.238
.045*
.004*
Step 3 Social
Emotion
.296
.053
HTN
.634
.091**
Flu
-.304
-.059*
SHC
.958
.142**
ETOH 6
-.218
-.048
Housing
.159
.068*
Note: Resp inf= respiratory infection, HTN=hypertension, SHC=Serious health condition, CHD=congenital heart
defect, BMI=body mass index
*p < .05, **p < .001

Table 7 (supplemental material)
Correlations Matrix: Simple/complex CHD and BW and GA
Biologic maternal context variables

BW¹

BW
1

GA

S/C

Race

Age

Diabetes

Bladder

Resp

GA¹

.690**

1

S/C³

-.014

.011

1

race²

.051*

.018

-.029

1

age¹

.062*

-.037

-.062*

-.013

1

diabetes ³ .043

.046

.048

.007

-.009

1

bladder³

.016

-.026

.003

-.069*

.107**

.019

1

Resp³

-.055*

-.047

.039

-.010

-.039

- .008

.019

1

HA³

.016

HA

Emotion HTN

Flu

SHC

Chic

CHD

.023

.034

.004

.069**

-.025

.105**

.264**

1

Emotion³ .034

.060*

.026

-.026

.018

.010

.168**

.027

.121**

1

HTN³

.118*

.109**

.024

.001

.032

-.005

.115*

.013

.116**

.070*

1

Flu³

-.049

-.050*

.005

-.013

-.049

.038

.061*

.191**

.096**

.042

-.002

1

Chixpox³ -.043

-.040

.006

-.021

-.009

-.009

.039

.058*

.045

.023

.035

.197**

1

SerHC³

.111**

.157**

.067*

-.025

-.014

-.015

.064

.019

.045

.093**

.128**

.034

-.023

1

CHD³

-.053*

-.043

.080**

-.004

.018

-.031

.047

-.002

.038

.065*

.028

.037

-.019

.060*

1

BDF³

.030

.008

.032

-.026

-.001

-.010

.043

.024

.019

.100**

.012

.019

.027

.049*

.161

BDF

1

Note. Comparisons were two-tailed and (1) Pearson’s r statistics, Spearman’s rho (2) or Phi Coefficient (3)
* Correlation is significant at the 0.05 level (2-tailed) **Correlation is significant at the 0.01 level (2-tailed)
*p=<.05, **p<.0006.
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Table 8
Correlations Matrix: Simple/complex CHD and BW and GA
Physical Maternal context variables
BW

GA

S/C

BMI

Obesity

Presdrug

MVI

H2O

Marij

Painkill

Smoke

BW¹

1

GA¹

.690**

1

S/C³

-.014

.011

1

BMI¹

.062*

.001

.045

1

Obesity³

-.093**

-.007

.018

-.645**

1

Predrug³

.004

.026

.024

-.047

.063*

1

MVI³

.000

.016

.005

.051*

-.024

.010

1

H20²

-.003

-.017

-.018

-.036

.033

.028

.012

1

marij³

-.016

-.011

.001

.019

-.032

.007

.027

-.011

1

painkill³

-.043

-.028

.019

.094**

-.128**

-.107*

-.009

-.025

.165

1

smoke_³

.029

-.011

.023

-.029

.056*

.053*

-.070**

-.011

-.111**

-.092**

1

ETOH6mo³

-.047

-.050*

.015

.056*

.031

.038

.094**

.024

-.036

.014

.164**

ETOH 6 mo

1

Note. Comparisons were two-tailed and (1) Pearson’s r statistics, Spearman’s rho (2) or Phi Coefficient (3)
* Correlation is significant at the 0.05 level (2-tailed)
**Correlation is significant at the 0.01 level (2-tailed)
*p=<.05, **p<.0006
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Table 9
Correlations Matrix: Simple/complex CHD and BW and GA
Social Maternal context variables
BW
GA
S/C

Marital

Annual
income

Education

housing

Work
before

BW¹

1

GA¹

.690**

1

S/C³

-.014

.011

1

Marital²

.040

-.039

-.038

1

Annual income¹

.077**

.002

-.074**

.416**

1

Education¹

.033

-.018

-.075**

.299**

.547**

1

Housing²

.001

.049*

-.015

-.165**

-.389**

-.267**

1

Work before³

.045

.033

.006

-.095**

-.173**

-.169**

.055

1

Work during³

.045

.020

.006

-.103*

-.191**

-.190**

.083**

.752**

Work
during

1

Note. Comparisons were two-tailed and (1) Pearson’s r statistics, Spearman’s rho (2) or Phi Coefficient (3)
* Correlation is significant at the 0.05 level (2-tailed)
**Correlation is significant at the 0.01 level (2-tailed)
*p=<.05, **p<.0006.
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Table 10
Correlations Matrix: Simple/complex CHD and BW and GA
Birth outcomes
Birth weight
Gestational age
Birth weight¹

1

Gestational age¹

.690**

1

Simple/complex CHD³

-.014

.011

Simple/complex CHD

1

Note. Comparisons were two-tailed and (1) Pearson’s r statistics, Spearman’s rho (2) or Phi Coefficient (3)
* Correlation is significant at the 0.05 level (2-tailed) **Correlation is significant at the 0.01 level (2-tailed)

*p=<.05, **p<.001.
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Chapter 5
The purpose of this study was to provide of synthesis of the manuscripts including
a review of literature on the maternal risk factors for congenital heart defects CHD and
the known genetic risk factors for CHD. A discussion of the findings from the
dissertation study that identified significant relationships between the maternal context
factors and the birth outcomes of their infants (type of CHD-simple/complex, birth
weight, and gestational age) is provided. This chapter begins with a synthesis of the
manuscripts and continues with a discussion, limitations, and future implications in
theory, practice, education, research and policy.
Synthesis of Manuscripts
A review of literature of all CHD was performed to gain an enhanced
understanding of the risk factors for CHD in the mother was the focus of the dissertation
and the hypothesis. The exploratory research questions regarding birth weight and
gestational age were undertaken to better understand and explain the type of CHD in this
dataset. The first manuscript titled, “Association of Maternal Risk Factors and CHD”
provided an examination of the current state of the science of the maternal context factors
associated for having an infant with CHD. In this review of literature, identification of
the maternal risk factors associated with CHD during pregnancy was analyzed and sorted
into maternal context variables of biologic, physical and social contexts using a life
course perspective. An abundance of literature was discovered initially and was
narrowed to provide the most recent research. The majority of the literature was written
by medical or epidemiological disciplines with limited literature in the nursing domain.
In this review the studies consisted of population based, registry based, case control or
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retrospective studies conducted worldwide. Several reviews were also discovered, which
discussed specific maternal risk factors for CHD but, none of which contained all of the
maternal contexts of interest in one study (Gorini, Chiappa, Gargani, & Picano, 2013;
Luteijn, Brown, & Dolk, 2013; Patel & Burns, 2013; Stothard, Tennant, Bell & Rankin,
2009; Jenkins at al., 2007; Thulstrup & Bonde, 2006; Watson, Jacobson, Williams,
Howard & DeSesso, 2006; Lin & Ardinger, 2005).
In the first manuscript, a review of literature of maternal CHD risk factors in
pregnancy was conducted using the theoretical life course perspective as the context
within which to place findings. The intention of the life course perspective is to
understand, explain and improve health and disease patterns across various populations
(Halfon & Hochstein, 2002). The life course perspective employs key components
including timelines, timing, environment, and equity of health (Kotelcheck, 2011; Fine &
Kotelcheck, 2010). These key components reflect the multilayer complexity of human
life and health which is helpful when discussing a complex disease process such as CHD.
Using this perspective allowed for arrangement of the risk factors identified in the
literature under the realms of biologic, physical and social contexts. A conceptual
framework was developed from the review of literature and framed using the life course
perspective which then guided the dissertation study (see Figure 1).
In this review the maternal contexts associated with CHD identified in the
literature included the biologic contexts of known genetic causes, maternal age, race,
chronic health conditions, and family history of CHD; the physical maternal contexts of
obesity, substance use, medication and vitamin use, and water consumption; and the
social maternal contexts of socioeconomic status, occupation history, and educational
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level (Gorini, Chiappa, Gargani, & Picano, 2013;Luteijn, Brown, & Dolk, 2013; Patel &
Burns, 2013; Stothard, Tennant, Bell & Rankin, 2009; Jenkins at al., 2007; Thulstrup &
Bonde, 2006; Watson, Jacobson, Williams, Howard & DeSesso, 2006; Lin & Ardinger,
2005). These maternal risk factors were found to be risk factors for developing CHD in
their fetuses. Although, these risk factors were identified, many of the researchers
recognized the limitations for accurately measuring the types of exposures, isolating the
types of exposures, or identifying immediate causal relationships of the risk factors for
CHD due to the multifactorial nature. Many researchers commented on the need for
continued research of the etiology of CHD. Some suggested larger sample size and
prospective studies to provide other perspectives to better understand the risks for CHD
development in the fetus.
As a result of this review of literature, it was recognized that the current studies
separated many of the maternal risk factors and did not provide a comprehensive review
for all the maternal context variables. Small samples, others with methodological flaws
and inability to accurately measure the variables associated with greater risk for CHD
were identified in this process. It was also recognized that the genetic influence toward
CHD must be elaborated separately to best appreciate the influence on CHD
development. Therefore the second manuscript reviews the known genetic influences on
CHD development.
The second manuscript titled, “Understanding Genetics and Pediatric Cardiac
Health” was produced as the genetic association for CHD development was substantial
and required further discussion. The objective of this manuscript was to provide a review
of the known genetic pathways and risk factors associated with CHD development for
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nurses and health care providers (HCPs). This manuscript provided an overview of
inheritance patterns, identified genes associate with CHD, and discussion of the
additional educational, clinical and research needed to better understand genetic CHD
development. During the construction of this manuscript, limited nursing literature was
found on this topic illustrating a need for greater understanding and integration of
genetics into nursing practice and research. The majority of literature was found in the
medical and epidemiological disciplines and well describes the known genetic influences
on CHD formation.
The reviews of the maternal risk factors for having an infant with CHD helped
identify the need to understand these risk factors. It was then proposed that these
maternal contexts could influence the type of CHD in the infant. In this review the studies
were case control with the majority studying the risk for general CHD rather than type of
CHD. Some studies reviewed prevalence of the types of CHD, but no study was
identified which compared risk for simple verses complex CHD, and if greater risk for
complex CHD was present when more maternal contexts were present. This is the first
study reviewing the maternal data from 2000-2010 in the WPCR database. Due to the
lack of a robust control group a hypothesis was derived using the dependant variabletype of CHD (simple or complex) as there was an adequate sample size to provide
comparison. The dissertation study was conducted using a life course perspective as this
model acknowledges the multilevel interactions and trajectories of the mother. Using
data within the WPCR from 2000-2010 exploration of the maternal data was performed
to identify relationships to types of CHD (simple or complex). Two hypotheses and one
exploratory research questions were asked.
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Hypotheses 1: Multiple maternal risk factors of biologic (known genetic causes
associated with CHD, age, race, chronic health conditions, family history of CHD),
physical (history of obesity, use of alcohol, drugs, cigarettes, medication/vitamin use, and
type of water consumed), and social variables (SES, occupation, education level)
influence the risk of complex CHD.
Hypothesis 2: Multiple maternal risk factors (biologic, physical, social) influence the
risk of low birth weight and/or early gestational age in the infants born with CHDs.
The third manuscript was constructed from this study, and is titled, “Maternal
Health and Infants Born with Congenital Heart Disease: A Secondary Analysis of the
WPCR”. This manuscript provided the study design, methodology and results of the
dissertation study. In this study 1,687 completed questionnaires from 2000-2010 were
used with focus on maternal and infant pre-conception and inter-conception history. The
maternal history was self reported information and the infant history was a combination
of reported information from the caregiver and clinical data provided by the research
team. After thorough cleaning of the data, 29 questions were used to represent the 14
maternal context variables organized according to the conceptual model (see Figure 1).
Descriptive analysis was conducted using these variables which provided rich
demographic, health and social history information for this population. These variables
were then analyzed for relationships between the maternal context variables and types of
CHD and infant birth outcomes in which the significantly correlated variables were
retained in the final analysis. The infant birth outcome of simple or complex CHD was
developed from a model used in the larger Baltimore Washington Infant Study (Ferencz,
Loffredo, Correa-Villaseñor, & Wilson, 1997) which the WPCR was modeled after. The
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type of CHD was used to compare differences in this population as there was not an
adequate control group available. With this large data set the comparison of risk for
simple or complex CHD in this group was performed using logistic regression.
The WPCR went through several transitions over the years, moving from a print
questionnaire and paper data source to completely electronic database. Due to these
changes, during the cleaning of this dataset some variables were eliminated due to
inconsistencies and concern for error and poor reliability. Data entry and interrator
reliability was not able to be accurately assessed therefore text in variables were used
cautiously. Education was the only text in variable retained in the final analysis and was
re-coded into a categorical variable. All other variables for the final analysis were either
continuous or categorical variables.
Another concern with using a large pre-existing data set was missing data. With
guidance and constant review of the data from a statistician, missing values analysis was
performed. In this dataset the variables selected did not contain significant amounts of
missing data therefore a listwise deletion method was not used to preserve the entire
dataset. The majority of missing data was < 10% missing, and the data missing more than
10% was well below 50%; therefore multiple imputations were used to impute the
missing data (Tsikriktsis, 2005).
From the analysis of this dataset the third manuscript provided a discussion and
presentation of the results of this study. The main findings of this study included two
significant predictors for having a child with complex CHD. These two variables,
maternal history of CHD (OR 2.382, 95 % CI, 1.424-3.984) and history of serious health
condition (OR 1.537, CI 1.085-2.178) showed a greater risk for having an infant with
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complex CHD. The women with reported personal history of CHD were 2.4 times more
likely to have an infant with complex CHD. Although, this study was not a case control
and cannot infer generalization to infants without CHD. The findings in this study was
consistent with the literature, in which first degree family members with history of CHD
had a 2-4 fold increased risk of any CHD in their offspring (Hinton et al., 2007; Lin &
Ardinger, 2005; Ferencz et al., 1989). In Caputo et al. (2005) large case control study,
they did not find a significant risk relationship in simple CHD (atrial septal defects).
However, In Nora et al. (1969) study of atrial septal defect (ASD) and ventricular septal
defect (VSD) inheritance risk, a 2.6-3.7% higher risk was noted. The majority of infants
in this study (73%) had simple CHD, with about 1/3 of the infants having complex CHD
(27%). This study supports the findings of having a first degree relative as a risk factor
for complex CHD.
In the current study, history of a serious health condition was a significant
predictor for complex CHD in the infant and is supported as a risk factor for CHD in the
literature. This group of women was 1.5 times more likely to have an infant with complex
CHD if the mother reported a serious health condition prior to or during the pregnancy.
This variable was measured as a yes or no answer with the ability to text in the type of
serious health. When the text comments were reviewed this variable was described by
the mother with many different serious health conditions provided. The mother reported
what they felt as a serious health condition. With this in mind this variable must be
interpreted cautiously as the serious health conditions were defined loosely by some of
the mothers in this study and may be difficult to accurately define a serious health
condition. For example some mothers reported history of gestational diabetes, pre-
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eclampsia, and falls as a serious health condition. Others did not specify the type of
serious health condition.
Serious health conditions and several other chronic health conditions were
included in the maternal context variable of chronic health conditions; which included
history of hypertension, diabetes, flu, bladder infections, history of emotional disorders,
chicken pox, and headaches as the literature found these conditions to be risk factors for
CHD. Only the significantly correlated variables in this study were retained for the final
logistic regression. History of a serious health condition six months prior or during
pregnancy was the only significantly correlated chronic health condition found in the
analysis. The finding from the current study supports the previous conclusions in the
literature of having a serious health condition as a risk factor for having a child with a
complex CHD. In the literature many serious and chronic health conditions were
combined or grouped together, such as history of fever, diabetes, hypertension, and viral
illnesses. Two studies identified that the timing of the serious health condition
particularly early in pregnancy was important, as greater risk for CHD was observed
(Oster, Riehle-Colarusso, Alverson, & Correa, 2011; Zen et al, 2011). Serious and
chronic health conditions were noted to be risk factors for CHD including fever, diabetes,
hypertension, and viral illnesses (Oster, Riehle-Colarusso, Alverson, & Correa, 2011,
Stothard, Tennant Bell, & Rankin, 2011, Zen et al, 2011). This study did not support the
history of diabetes, fever, hypertension or viral illness specifically; however, some
mothers in the text descriptions of serious health conditions reported these conditions.
Timing of the serious health condition is important to note. When illnesses occur either in
the pre- or inter-conception timeframes, or first trimester can be important to determine
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risk for CHD. Febrile illnesses in the first trimester have been associated with increased
risk of all CHD (Oster, Riehle-Colarusso, Alverson, & Correa, 2011; Zen et al, 2011).
Maternal self report of serious health conditions was identified in this study to be
a greater risk for having an infant with complex CHD. However, some caution should be
made in this finding as the specificity of the serious health condition is not present. Also,
when looking at the timing of the illness or serious health condition the timeframe of the
questions is quite broad (6 months prior to or during the pregnancy) in which some of the
serious health conditions may be a chronic problem and not accurately represented.
A second hypothesis was tested to determine if predictors for gestational age and
birth weight were present in this study. To test this hypothesis hierarchical multiple
regressions were used. Predictors of birth weight included; maternal history of
hypertension, serious health condition six months prior/during pregnancy, CHD, obesity
and income level. In the final regression model 4.4% of the variance of birth weight of
these infants with CHD was explained, R² change = .044, F change (1, 15911) = 10.125,
p < 0.05.
In this sample of infants with CHD, the maternal context variables that had the
most influence on birth weight in the regression model included; maternal chronic health
conditions of hypertension or serious health conditions, history of maternal CHD, history
of obesity and income level. This study supports the literature and risk for having a low
birth weight infant if specific maternal context variables are present such as obesity and
lower incomes levels (Messer et al., 2008). In pregnancy, maternal chronic health
conditions are important to address as they can be predictors for the birth outcomes of
gestational age and birth weight (CDC, 2011; UNICEF & WHO, 2002). This study was
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consistent with the literature describing maternal risk factors of having an infant with low
birth weight but the relationship was small as only 4.4-4.5% of the variance was
described in the model. There are many influences of gestational age and birth weight in
this sample that were not elicited from this model.
A hierarchical multiple regression was performed to assess predictors of
gestational age in the group of infants with CHD. Predictors of gestational age included;
maternal history of hypertension, flu, and serious health conditions 6 months prior/during
pregnancy, and type of housing. In the final model 4.5% of the total variance of
gestational age was explained, R² change = .004 F change (1, 1680) = 7.875, p < 0.05.
Findings from the current study support the literature that associated maternal
history of chronic health conditions (diabetes, hypertension, obesity) as a greater risk for
having a premature infant as described above (Di Renzo, et al., 2011; Magnussen, Jatten,
Myklestad, Salvesen, & Romundstad, 2011). Maternal history in the preconception
period of diabetes (OR -0.6, CI; -2.1 to 0.8), hypertension (OR -1.8, CI; -3.2 to -0.5) and
high cholesterol (OR -1.8 CI; -3.2 to -0.3) were associated with preterm birth < 37 weeks
(Magnussen et al., 2011). The type of housing was also found to be a variable influencing
the risk for prematurity and is consistent with the findings in Messer et al.’s (2008)
census data study finding a small association between poor housing and preterm birth
(OR 1.1-1.7). The majority women in this study with both simple and complex CHD
infants predominantly lived in single family homes, educated and had middle to upper
class income levels. However, the remainder of the participants may have been
representative of a lower SES, with risk for nutritional deficiencies and environmental
exposures which may explain the poorer birth outcomes. There were no reports of
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homelessness, although this was not an option in the questionnaire. The BWIS (Ferencz
et al. 1997) found in the women with lower SES a greater risk for CHD, particularly
laterality and looping defects. The findings of this study supports the literature in which
maternal health history and SES is crucial in the infants’ birth outcomes of birth weight,
gestational age, and risk for CHD (Patel, 2012; Kučienė & Dulskienė, 2009). However
the majority of the variance in this sample was not described in the model with ~95% of
the predictors for gestational age and birth weight unable to be determined from this
study.
The exploratory research question was posed, “Does the type of CHD (simple or
complex) influence birth weight, and gestational age in infants born with CHD?” It was
believed that the more complex the CHD the greater the risk for prematurity and low
birth weight would be observed. However, in this study group of infants with CHD, type
of CHD (simple or complex) was not significantly correlated to birth weight and
gestational age, BW= -.014, GA .011, r). In this study, gestational age and birth weight
were not found to influence type of CHD. The complex CHD infants did not overall have
lower birth weights (simple, mean BW 3.18 kg vs. complex 3.16 kg) or history of
prematurity (simple mean GA 37.91 weeks vs. complex 37.96 weeks) in this sample. In
fact this group of infants with CHD was found to have generally normal mean birth
weights and normal gestational ages.
In the literature, CHD has been associated with small for gestational age and
lower birth weights (Malik, Cleves, Zhao, Hobbs & NBDS, 2007). Malik et al.’s (2007)
study was a case control study which compared the severity of the heart defect and risk
for low birth weight and gestational age. In Malik et al’s (2007) study, a system which
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categorized simple CHD as a single lesion verses associated CHD which combined
several CHD diagnoses was used. They found a significant difference in the small for
gestational age in the simple (OR 1.96, CI; 1.67-2.30) versus the associated CHD groups
(OR 2.54; CI; 1.99-3.23). The simple CHD cases represented 82.4% of the cases,
whereas the associated cases represented less than 20% of the cases in this study.
Limitations
Using a large data set has many positive features; access to large samples, and
cost-effective to the novice researcher as the data has already been collected, access
multiple variables to analyze, and access to data which may not otherwise have been
easily collected by nursing (Aponte, 2010; Pollack, 1999). As with the benefits of
secondary analysis come limitations. The data was collected prior to the development of
the hypothesis or research question, and congruency of the questions asked or tested can
be compromised or may need to be altered dependent on the data (McCall & Appelbaum,
1991).
A major limitation of the WPCR was the lack of specific data on the timing of
exposures. There were many variables included in this study; however, the dose response
to exposure could not be elicited. The questions in the WPCR were not specific enough to
isolate a critical time period prior or during pregnancy for exposures. Many of the
maternal co-morbid conditions were collected as a yes/no question to having or being
exposed six months prior to or during the pregnancy and text in variables avoided due to
inability to accurately or reliably code.
Recall is a significant concern in the collection of maternal data. The questions
were all asked, “Did an event occur prior or during pregnancy?” The WPCR tried to
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decrease recall bias by enrolling infants less than two years of age and their caregivers to
the study. Variables were chosen to avoid large amounts of missing data. But because of
this there is limited information. Text in variables was not used therefore this study loses
some ability to understand the complexity of CHD and use of sensitivity of this
information.
From review of the literature, sensitive questions such as smoking, alcohol and
drug consumption are known to be variables of bias and may not be accurately answered
by the participants (Polit & Beck, 2008). Smoking, drug and alcohol history were
included in this study and used with caution in the interpretation of results. Even though
this study chose these variables with little missing data, sensitive questions are still
problematic. In the analysis of missing data; these questions had more missing data than
the other variables particularly if there were several questions associated with that
variable. Therefore only yes/no questions were included in the analysis.
Generalizability of the results may be limited as the sample included only mothers
of infants born in the state of Wisconsin from 2000-2010. Wisconsin was a
predominantly Caucasian, middle class, Midwestern state during the data collection
period, which may not be representative of other demographic locations in the United
States. The sample in this study represented approximately 1/3 of the known infants and
children with CHD who were approached to participate in the WPCR (1,687/4,919) and
thus even the generalizability of findings to families in the state of Wisconsin may be
limited (Harris et al., 2011).
In this study comparison between types of CHD (simple and complex) were used
due to lack of a robust control group. The sample was large and provided the power to
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answer the hypotheses. Although the WPCR began collecting a control group in 2007,
the majority of the controls enrolled were adolescents seen for chest pain, syncope or
murmur. Financial ability was a concern initially to enroll a control group. The control
group when started was used to compare the genetic component, which the control group
did not provide the type of data which would be useful for comparison to this data.
However, after a decade of collection the WPCR changed the questionnaire
dramatically to adjust for concerns of reliability, consistency, and inability to draw
conclusions from some of the questions asked. This poses concerns of the reliability of
some questions used for the analysis in this study. Although, these concerns and
limitations are present, this study was able to identify several maternal risk factors for
type of CHD and the birth outcomes of these infants. Although the relationships in this
study were small, these maternal context variables were associated with greater risk for
complex CHD, lower birth weight and prematurity. The multiple and logistic regression
results must be interpreted with caution as they do not imply causality (Pallent, 2007).
More importantly this study provided a descriptive analysis of the maternal and infant
data collected from 2000-2010.
Implications
Implications for Theory
The conceptual model was generated using literature that identified variables
associated with risk for CHD development prior to and during pregnancy in women.
From this review of literature sufficient gaps regarding the factors associated with the
risk for developing a complex CHD were found and therefore this study undertaken to
test these relationships
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The results of this study generally supported the relationships of the maternal
context variables to risk for infant outcomes delineated in the conceptual framework.
However the study did not support every domain (biologic, physical, or social) or every
variable in these domains. The biologic domain was the only category predicting risk for
complex CHD. The physical and social domains did not reveal significant relationships.
Similarly, the physical domain did not predict gestational age. These findings may be
related to the positive health practices of the sample, the measurement of the variables, or
to the lack of diversity in the sample. For CHD, this lack of relationship could also be
related to the timing of the CHD development in which the other domains are not as
influential for affecting type of CHD, as CHD development occurs early in gestation. It
is possible that once the CHD occurs it is only biological factors that determine the type
of CHD. Measurement of context variables available for the study may also have been
problematic. Variables with greater specificity as well as objective measures of the
concepts should be considered for future studies. The lack of diversity could have also
limited the findings of social variables on outcomes.
An interesting finding was the lack of support for greater risk of low birth weight
or prematurity in the infant with complex CHD. This finding differs from others in the
literature where having CHD and particularly, complex CHD has been found to be a risk
factor for premature birth and low birth weight in other studies (Williams et al., 2010;
Malik, Cleves, Zhao, Hobbs, & NBDS, 2007). It is possible that once the CHD occurs it
is only biological factors that determine the type of CHD
This was the first test of the proposed conceptual model. Although five
relationships were not supported (physical and social to CHD; physical to gestational age
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and CHD to birth weight and gestational age it is premature to revise the model based
only this study. This is particularly true for the lack CHD to birth weight and gestational
age where evidence of a relationship exists in the literature. Further research with
demographically, geographically and ethnically diverse samples would be important to
conduct for a robust test of the model.
Practice
The findings of this study have several implications for practice. The study
showed an increased risk for complex CHD when the mother reported personal history of
CHD or history of a serious health condition prior to or during the pregnancy. HCP’s
should pay particular attention to women with a serious health condition and discuss with
women of childbearing age the importance of alerting their HCP of any significant health
care concern when it occurs. HCP’s can have a discussion with these women if a
pregnancy is being planned and these risk factors are present to allow planning. In the
recent publication from the AHA regarding management of fetal cardiac disease,
parameters for intervention and scanning increased prenatal risk of CHD are provided
(Donofrio et al, 2014). For example, if a mother has personal history of CHD, history of
rubella, diabetes, or specific medication taken during the beginning of the pregnancy a
fetal echo is recommended between 18-22 weeks gestation to screen for CHD. The
findings of this study which is now concluding are in concert with the recommendations
published within the Scientific Statement for the care of fetal cardiac disease. This study
supports the recommendations for thorough screening of family history, maternal health
history particularly history of CHD, CHC’s and/or infections to identify fetuses at risk for
complex CHD and CHD in general. Early fetal diagnosis is critical in the prevention of
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the increased morbidity and mortality associated with undiagnosed fetal CHD. A fetal
echocardiogram may be performed in such cases when maternal history of CHD or
serious health conditions are present, thus allowing for referral to perinatology, delivery
coordination, or options for continuation of the pregnancy to be discussed.
Although, this study focuses on risk for type of CHD (simple or complex),
maternal risk factors were identified in the literature review (Butler et al., 2014)
identifying risks for all CHD. Identification of maternal CHD risk factors should become
regular part of women’s care. Nurses and HCPs, whether at the beginning of their career
or those who are experienced require continuing education in maternal health and
promotion of healthy pregnancies. There is an expectation to maintain competency in
these areas of healthcare, we must provide these resources for success. Continuing
education may include case studies, case review, and morbidity and mortality discussions
among the healthcare team as a regularly scheduled commitment to maintain up to date
competency.
This study found that serious health conditions and maternal history of CHD to be
risk factors for complex CHD. So recognition of serious health conditions and chronic
health conditions (Liu et al., 2013; Oster, Colarusso, Alverson & Correa, 2011) and first
degree family history (Romano-Zelekha et al., 2001) are important as the literature
identified these maternal contexts as risk factors for all CHD development. It is
important for HCPs to be aware of their patients’ health and family history as this
information may alert the HCP of risk factors for CHD which could be flagged on the
electronic health records when planning of future pregnancies.
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Investigators continue to study the influences of epigenetic factors and
generational health practices in the risk for CHD development. A thorough health history
of the mother and father may provide the ability to identify risk factors for birth defects,
particularly CHD and should be expected as a standard of care (Seibert, 2010). HCPs can
identify these risks and counsel families and future generations of good healthcare
practices prior to pregnancy to help decrease the risk of CHD and other infant diseases.
As healthcare systems shift to a prevention model for healthcare delivery, nurses are
uniquely positioned to identify and educate these men and women of childbearing age
and can convey this information to decrease risk of CHD.
Education
In this study maternal history of serious health conditions and history of CHD
showed an increased risk for complex CHD in the infant. Nurses requires educational
resources which encompass the pre-conceptual health promotion practices for both
women and men of childbearing age to identify risk for complex CHD and CHD in
general. Education strategies to promote a greater understanding of the complexity of the
environmental and genetic risk factors for CHD must be incorporated at all levels of
education. Interactive dialogues and examples between instructors and students of
normal pregnancy recommendations followed by the abnormal findings associated with
CHD to illustrate the importance to be aware and ask questions to elicit information
which can impact the care.
In 2001 the American Heart Association (AHA) and the National Heart, Lung,
and Blood Institute (NHLBI) recognized that a greater understanding by all HCPs of the
environmental and genetic influences was essential. An expert panel produced a policy
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statement to share recommendations for education, research, and need for creation of
interdisciplinary teams in the study of genetics and CHD (Ashley et al., 2012). This
panel provided recommendations to address each discipline of HCP’s separately but
recognizing a need all HCP’s to receive education in genetics. Therefore the “Core
Competencies in Genetics for Health Professionals” was published in 2007. As only 1015% of CHD etiologies are attributed to chromosomal or single gene mutations (Brent,
2004; Botto & Correa, 2003) with new research discoveries occurring rapidly the
educational resources for HCPs require updates to reflect the new knowledge acquired.
Future Research
CHD is an elusive birth defect affecting multiple families worldwide. This study
revealed two maternal context factors influencing the risk for complex CHD. However,
as only 5% of the variance of the model was described by these contexts additional
research is needed to understand the 95% of unexplained relationships. The majority of
the influences of CHD were unexplained in this study; similar to much of the literature
reviewed when studying non-genetic risk factors for CHD all which suggested the need
for continued research (Fung et al., 2013; Patel & Burns, 2013; Jenkins et al., 2007). The
NHLBI supports new research when studying CHD. A task force was created with focus
on several areas of basic research, clinical outcomes research, and translational research
with the hope of reducing CHD (NHLBI, 2001). Using a model which compared type of
CHD may provide a different lens to view the risk factors for CHD. All of these women
in this study appeared generally healthy but had infants with various forms of CHD, and
approximately 1/3 with complex CHD. Future studies may also increase delineation
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between severity of CHD and these risk factors between these groups in the analysis as
well.
This study identified significant relationships between the maternal context
variables and infant outcomes in this sample. There were several maternal context
variables identified which influenced birth outcomes, however the majority of the
variance in the models was not explained. Future research needs to include the paternal
contexts which may provide a greater understanding of risk for CHD. The risk of
complex CHD in this sample provided another perspective on CHD development other
than case control methods. This may allow understanding of the subtle differences in the
mother’s health when all had an infant with CHD. Most research stressed the need for
more research isolating variables and exposures. This study may provide another method
to view affects of health practices on the severity of CHD.
Policy
Secondary analysis may provide and avenue to advance science and the science of
understanding CHD. However, attention to the quality and maintenance of the data must
be acknowledged. The WPCR was helpful providing a glimpse of the maternal and infant
data. In a time limiting funding opportunities secondary analysis can be advantageous
method of research. As new researchers, locating large repositories of data may provide
resources, previously unavailable to aid in the answers to research questions or
development of new hypotheses. This study helped to recognize the needed skills,
resources and expertise to use a large dataset is important in the success of the study. A
multi-disciplinary team approach would be recommended to better understand the dataset
to recognize the strengths and limitations of particular variables.
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The AHA created an expert policy statement which highlights the relationship
between genetics and cardiovascular disease (AHA, 2012). Congenital heart disease is a
multifactorial process that requires a comprehensive approach recognizing the genetic
and environmental interactions. The AHA recently published recommendations for fetal
diagnosis and treatment of cardiac disease (Donofrio et al. 2014) that identified several
maternal and paternal health conditions or history that can increase risk for CHD in their
infants. These recommendations provide structured guidelines for nurses and HCP’s to
help identify and treat families who may be at greater risk for complex CHD and CHD’s
in general. This study and these guidelines may assist nurses and HCP’s in the treatment,
screening and counseling of families affected by CHD.
Conclusion
CHD continues to be the leading birth defect in the world leading with extremely
high rates of morbidity and mortality. Although, there have been immense advances in
the understanding of cardiac formation in the fetus, the majority of CHD etiology remain
unknown. This study identified maternal risk factors for having an infant with complex
verses simple CHD. These findings of maternal history of CHD and history of a serious
health conditions during pregnancy enhanced the understanding of the increased risk for
complex CHD in their infants. Because of numerous exposures during pregnancy the
importance of obtaining a complete health history is critical for identifying greater risk. It
is critical for nurses and healthcare professions to become aware of these risk factors
when caring for women of childbearing age so identification and interventions can
proceed. It is essential to continue the search for risk factors associated with CHD,
pinpointing the critical time frame for CHD development. Nurses and HCPs must remain
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active in CHD research, education and evidence based practice techniques to improve the
care provided to those affected by CHD. The findings of this study reinforce the necessity
to intensively and accurately review family history, medical history and social history of
all women of childbearing age. This particular cohort of women was overall healthy with
few co-morbid conditions or risky behaviors reported and still gave birth to infants with
CHD. Women are at risk for CHD, as nurses and healthcare professionals it is our
responsibility to promote positive health practices and be aware of risk factors providing
this valuable information to these patients.
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Appendix B
Wisconsin Pediatric Cardiac Registry
Questionnaire (abbreviated)
(Maternal and infant variables used in the study)
INSTRUCTIONS: This comprehensive questionnaire is being given to the families of infants born with
congenital heart defect in the state of Wisconsin. The information is important to our continuing efforts to
discover if there are identifiable causes of these defects. All information is strictly confidential. Prior to
completing this questionnaire you must have agreed to participate in the study and completed the required
consent form. The questionnaire will take approximately 1 hour to complete. Completing this survey is
voluntary. You may skip questions or quit at any time. You do not need to complete the entire questionnaire at
one session. Please return both the consent form and the questionnaire to the address on the cover page. Once
we receive your questionnaire, if there are questions that are left unanswered, the Registry Coordinator will
follow-up with a telephone call to obtain the information. If you have indicated that you decline to complete
those questions, we will not contact you further.
Medical terms are defined in a glossary at the back of this questionnaire.

If you need help answering any of the questions, please call the Registry Coordinator at:
(877) 809-9727 or 414-266-2325

2.

Sex:

4.

What is your child’s birth date?

5.
6.

male

female

What was mother’s expected delivery date?

____ / ____ / ____
month day

year

____ / ____ / ____
month day

year

When was mother’s last menstrual period prior to this pregnancy? ____ / ____ / ____
month day

Now we would like to ask you some questions about the baby’s mother and her health and family.
Please circle mother’s race or ethnic group:

8.

(a)
(b)
(c)
(d)
(e)
(f)

African-American
Asian
Caucasian
Hispanic
Native American
Other, please specify: ________________________________________________

9.

What is mother’s date of birth?

10.

What is mother’s marital status?
(a)
(b)
(c)
(d)
(e)

12.

____ / ____ / ____
month day

year

Single (never married)
Married
Divorced
Separated
Widowed

Did/does mother have a congenital heart defect, a heart condition that she was born with?
Yes*

No

Don't Know

* If yes, please circle the correct answer below or write in the diagnosis.
a)
b)

Ventricular septal defect
Patent ductus arteriosus

f)
g)

Atrial septal defect
Coarctation of the aorta

year
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c)
d)
e)

14.

Pulmonary valve stenosis
Tetralogy of Fallot
AV canal/endocardial cushion defect

h)
i)
j)

Aortic valve stenosis
Transposition of the great arteries
Bicuspid aortic valve
k)
Other (please specify):
________________________
_

Did/does mother have any birth defect, malformation, or condition other than heart disease which was
present from birth?
Yes*

No

Don't Know

*If yes, specify: ___________________________________________________________

Now we are going to ask about some illnesses that can last over a period of time and may sometimes have an
effect on pregnancy.

33.

Has mother ever been told she has diabetes?
Yes

No*

Don't Know

a)

Did mother have diabetes only during this pregnancy?

b)

During the 6 months before this pregnancy or during
this pregnancy did mother take insulin?

c)

Yes

No

Don't

Know

Yes

No

Don't Know

Yes

No

Don't Know

During the 6 months before this pregnancy or during
this pregnancy did mother take oral hypoglycemic
pills or capsules?

34. Has mother ever been told that she has any of the following illnesses?

Illness

Has mother ever had:
Illness
Treatment
Yes *
No
Yes *
No

Age at onset
(year)

Duration
(years)

a) Asthma or allergies
b) Epilepsy (seizures)
c) Thyroid disease (specify)
d)
e)
f)
g)

Systemic lupus (SLE)
Peptic ulcer disease
Eating disorder
Cancer (specify)

h) Other (specify)

35. In the 6 months prior to or during this pregnancy did mother have any of the following illnesses or
conditions?
Illness
Yes
a) High blood pressure
b) Obesity (overweight)

No

Treatment
Yes*

*If yes, please specify:
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c) Bladder or kidney infections
d) Emotional (psychiatric) problems,
including depression - please specify:
___________________________
e) Vaginal infection:
gonorrhea
syphilis
herpes
other, please specify:
f) Arthritis
g) Headaches
h) Colds, sinus infections, bronchitis,
pneumonia (please circle whichever
apply)

36. In the 6 months prior to or during this pregnancy did mother have or was mother exposed to anyone with the
following infections (if yes, check the appropriate time period):
Before
pregnancy -

Infection
Yes

No

During pregnancy

Indicate 1-6
months

(months)

1-3

4-6

7-9

a) Influenza (flu)
b) Mumps
c) Measles
d) Rubella
e) Chicken pox or shingles
f) Hepatitis
g) AIDS or HIV

39.

During this pregnancy did mother ever have a fever of 101F or higher?
Yes*

42.

No

Don't Know

In the 6 months prior to or during this pregnancy did mother have any other serious health problem or
was she hospitalized for any reason, excluding delivery?
Yes*

No

Don't Know

*If yes, please specify:
43.

Did mother take vitamins or multi-vitamins during this pregnancy?
Yes*

No

Don't Know
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*If yes, please list the brand name:
44.

Did mother take any other “over-the-counter” health food or herbal supplements during this pregnancy?
Yes*

No

Don't Know

*If yes, please list the brand name:
46.

____________

During this pregnancy, did mother regularly take any medication not mentioned above?
Yes*

No

Don't Know

*If yes, please specify: __________________________________________________
47.

What is mother's height?

48.

What was mother's pre-pregnancy weight?

49.

How much weight was gained during this pregnancy?

55.

Did mother ever smoke cigarettes?
Yes
a.)

No*

_______ft. ______in.
__________lbs.
__________lbs.

Don't Know

Did mother smoke during the 6 month period prior to this pregnancy?
Yes**

No

Don't Know

b.) Did mother smoke during this pregnancy?
Yes**

59.

No

Don't Know

During the 6 months prior to this pregnancy or during this pregnancy, did mother drink
any alcoholic beverages (beer, wine, or liquor)?
Yes

No*

Don't Know

64. During this pregnancy, did mother use any of the following drugs?
Drug Name

Frequency
Never

Cocaine
Marijuana
Hash or Hashish
Amphetamines (uppers, speed)
Pain Killers (Percocet, Percodan, etc.)
Glue Sniffing
Crack
Heroin
Barbiturates (Downers)
Valium
Other Drugs (please
specify)________________________

Rarely

Less than
once a
week

About
once a
week

Almost
daily
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69.

In what type of house did mother live?

72.

a)
Individual (unattached) house
b)
Row, duplex, or townhouse
c)
Apartment
d)
Trailer
e)
Other:________________________(specify)
What was the source of mother's drinking water during this pregnancy?

75.
taxes):

a.)

City water

b.)

Well water

c.)

Bottled water

d.)

Other, please specify: ______________________________________

Please look at the table and select the category that best represents the total annual family income (before

a.)
b.)
c.)
d.)
e.)
f.)

Less than $10,000
10,000 - 19,999
20,000 - 24,999
25,000 - 49,999
50,000 - 99,999
Greater than 100,000

77.

What is the highest grade of schooling mother has completed?

79.

Was mother working during the 6 months before she became pregnant?
Yes

84.

No*

________________

Don't Know*

Was mother working during this pregnancy?
Yes

No*

Don't Know

Now we would like to ask for some information about the baby.

131.

How much did he/she weigh at birth?

___ ___ lbs. ___ ___ oz.
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